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ABSTRACT
In mammals, DNA methylation is introduced by the
DNMT1, DNMT3A and DNMT3B methyltransferases,
which are all large multi-domain proteins containing
a catalytic C-terminal domain and an N-terminal part
with regulatory functions. Recently, two novel regu-
latory principles of DNMTs were uncovered. It was
shown that their catalytic activity is under allosteric
control of N-terminal domains with autoinhibitory
function, the RFT and CXXC domains in DNMT1 and
the ADD domain in DNMT3. Moreover, targeting and
activity of DNMTs were found to be regulated in a
concerted manner by interactors and posttransla-
tional modifications (PTMs). In this review, we de-
scribe the structures and domain composition of the
DNMT1 and DNMT3 enzymes, their DNA binding, cat-
alytic mechanism, multimerization and the processes
controlling their stability in cells with a focus on their
regulation and chromatin targeting by PTMs, interac-
tors and chromatin modifications. We propose that
the allosteric regulation of DNMTs by autoinhibitory
domains acts as a general switch for the modulation
of the function of DNMTs, providing numerous possi-
bilities for interacting proteins, nucleic acids or PTMs
to regulate DNMT activity and targeting. The com-
bined regulation of DNMT targeting and catalytic ac-
tivity contributes to the precise spatiotemporal con-
trol of DNMT function and genome methylation in
cells.
INTRODUCTION
In mammals, DNA methylation occurs at the C5 position
of cytosine residues, primarily in CpG dinucleotides, 60–
80% of which are methylated in a tissue and cell type spe-
cific pattern (1–5). The correct methylation pattern is es-
sential for development and differentiation of cellular phe-
notypes, and aberrant DNA methylation is a driving force
in the onset and progression of several diseases, in particu-
lar cancer (6–9). Recently, the presence of 6-methyladenine
in mammalian DNA has been discovered (10–13), but re-
ported m6A levels are low, its biological roles are still un-
clear and the responsible enzymes have not been identified
yet; therefore, it will not be considered further in this review.
DNA-(cytosine C5)-methylation is introduced during
early development of mammals and maturation of germ
cells by two related DNA methyltransferases (MTases),
DNMT3A and DNMT3B, with the help of the stimulatory
factor DNMT3L. DNMT3A and DNMT3B were classi-
cally designated as de novomethyltransferases, because they
do not show any significant preference between hemimethy-
lated and unmethylated DNA substrates (14,15). They are
highly expressed in undifferentiated cells and germ cell pre-
cursors, but present at much lower levels in somatic cells.
In the cell nucleus, DNMT3 enzymes localize to pericen-
tromeric heterochromatin (16,17), where they are tightly
bound to nucleosomes containingmethylatedDNA (18,19).
After establishment, methylation patterns are preserved for
the rest of the life of an organism, with small tissue-specific
changes. During DNA replication, fully methylated CpG
sites are converted into hemimethylated sites, which are then
re-methylated mainly by the so-called maintenance methyl-
transferase DNMT1. This enzyme is present at the repli-
cation forks and preferentially methylates hemimethylated
CpG sites, thereby copying themethylation pattern from the
parental DNA strand onto the newly synthesized daughter
strand (3–4,20–22). DNMT1 is ubiquitously and highly ex-
pressed in proliferating cells, representing the major DNA
methyltransferase activity in somatic tissues throughout
mammalian development and is present only at low levels
in non-dividing cells (23). The sub-nuclear localization of
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DNMT1 changes dynamically during the cell cycle, it is dif-
fusely distributed in the nucleus during interphase, and lo-
calizes to the replication foci in S-phase creating a charac-
teristic punctuate pattern (24,25).
However, it has been recently recognized that this clas-
sification of DNA MTases into de novo and maintenance
methyltransferases is an oversimplification and that DNA
methylation is better described as a dynamic process of on-
going methylation and demethylation, in which DNMT1
and DNMT3 enzymes together play roles in both de novo
and maintenance methylation (1,26–27). This conceptual
change in the perception of DNA methylation as a dy-
namic process has important implications entailing that it
is the regulation and targeting of DNMTs that controls the
methylation state of each CpG site, and not the conceptu-
ally simple copy process brought about by DNMT1 after
DNA replication. However, the preference of DNMT1 for
the methylation of hemimethylated CpG sites is certainly
an important factor in the control of cellular DNAmethly-
ation patterns. Consequently, the complex role of DNA
methylation in human biology critically depends on the dy-
namic regulation and targeting of DNMTs by posttransla-
tional modifications (PTMs), as well as by their interaction
with other chromatin factors (e.g. histones), other interact-
ing proteins or nucleic acids.
The general architecture of all threemammalianDNMTs
is similar. They all are multi-domain proteins, in which two
functional parts can be distinguished, a large N-terminal
regulatory part and a smaller C-terminal part, harboring
the catalytic center (Figure 1) (3,20–21). The C-terminal do-
mains of DNMTs contain 10 conserved amino acid motifs
characteristic for DNA-(cytosine-C5)-MTases. They fold
into a widely conserved structure found in all enzymes of
this class, the so called ‘AdoMet-dependent MTase fold’,
which consists of a mixed 7-stranded -sheet formed by 6
parallel  strands and a 7th strand inserted into the sheet
in an anti-parallel orientation between strands 5 and 6. Six
alpha helices surround the central -sheet on both sides
(20,22). The C-terminal domain of DNMTs is involved
in AdoMet binding, DNA recognition and binding, target
base flipping and catalysis. It contains a non-conserved re-
gion, the so-called target recognition domain (TRD) that is
involved in DNA recognition and specificity.
The catalytic mechanism of DNA-(cytosine C5)-
methyltransferases has been elucidated using prokaryotic
DNAMTase as model systems more than two decades ago
(20,28). The transfer of the methyl group from the AdoMet
to the C5 position of cytosine residues is enabled by the
rotation of the target base out of the DNA double helix and
its incorporation into a hydrophobic pocket in the active
center of the enzyme next to the AdoMet, in a mechanism
called base flipping. The base flipping is common to all
DNA methyltransferases and it has recently been observed
in the crystal structure of DNMT1, the first mammalian
DNMT co-crystallized with its substrate DNA (29). The
methylation of the C5 position of cytosine follows a two-
step reaction mechanism. First, a catalytic cysteine residue
located in the PCQ motif attacks the C6 position of the
cytosine ring, leading to the formation of a covalent bond
between the enzyme and the substrate base. This process
leads to the activation of the C5 position and methyl group
transfer. The addition of the methyl group to the base is
followed by a deprotonation of the C5 atom, which resolves
the covalent bond between the enzyme and the base in an
elimination reaction (20,28). Kinetic isotope effects have
recently confirmed this two-step mechanism for DNMT1
(30). In addition, mutations of the key catalytic residues
in DNMT3A were found to reduce its catalytic activity,
although in some cases unexpected residual activity was
observed (31–33).
The N-terminal parts of DNMTs, which are different be-
tween the DNMT1 and the DNMT3 family of enzymes,
comprise several domains with regulatory functions. They
guide the nuclear localization of the enzymes, mediate their
interaction with other proteins, regulatory nucleic acids
(like non-coding RNAs) and chromatin, and are subject
to post-translational modifications. Moreover, recent struc-
tural and biochemical data have demonstrated that the ar-
rangement of these domains plays a central role in the regu-
lation of the biological functions of DNMTs, because they
are involved in the allosteric regulation of the enzymes’ ac-
tivity, specificity and localization.
STRUCTURE, MECHANISM AND REGULATION OF
DNMT1
Domain composition of DNMT1
DNMT1 is a large enzyme, occurring in different iso-
forms generated by alternative splicing and the usage of
an alternative promoter (3,21). DNMT1 contains multiple
functional domains located in its N-terminal part that is
joined to the C-terminal part by a flexible linker composed
of lysine-glycine (KG) repeats (Figure 1). The N-terminal
part serves as a platform for the assembly of various pro-
teins involved in the control of DNA replication and re-
pair, chromatin structure and gene regulation. It is com-
posed of several domains that are listed here in the or-
der from the N- to the C-terminus. The DMAP1 (DNA
methyltransferase-associated protein 1) interaction domain
contacts the transcriptional repressor DMAP1. With this
interaction, DNMT1 targets DMAP1 to replication foci
throughout S phase (34). DMAP1 influences maintenance
methylation by DNMT1 in early development (35) and af-
fects the stability of DNMT1 in cells (36). The PCNA (pro-
liferating cell nuclear antigen) binding domain (PBD) is in-
volved in the targeting and tethering of DNMT1 to the
replication fork during S phase that supports DNA methy-
lation in cells (37,38). It also contains an AT-hook-like
DNA binding motif (39). The replication foci targeting do-
main (RFTD) is involved in the targeting of DNMT1 to
replication foci (25) and centromeric chromatin (24). It in-
teracts with UHRF1 (ubiquitin-like with PHD and ring fin-
ger domains 1) protein (40,41) that binds to hemimethy-
lated DNA and chromatin modifications and also contains
a RING E3 ligase domain. The RFTD domain is followed
by the CXXC domain, which binds unmethylated DNA
(42–44) and comprises a zinc finger containing eight cys-
teine residues and two zinc ions. Finally, the BAH1 and
BAH2 (bromo-adjacent homology 1 and 2) domains are
necessary for the folding of DNMT1. It is currently un-
known whether they have further functional roles, although
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Figure 1. Domain structure of the mammalian DNMT enzymes. The human DNMT1, DNMT3A, DNMT3B and DNMT3L proteins consist of 1616,
912, 853 and 387 amino acid residues, respectively. Abbreviations used: DMAPD – DNAmethyltransferase associated protein 1 interacting domain, PBD
– PCNA binding domain, NLS – Nuclear localization signal, RFTD – Replication foci targeting domain, CXXC – CXXC domain, BAH1 and BAH2 –
bromo-adjacent homology domains 1 and 2, GKn – glycine lysine repeats, PWWP – PWWP domain, ADD – ATRX-DNMT3-DNMT3L domain.
chromatin targeting by a BAH domain has been described
in plant DNMTs (45).
Structure of a catalytically active DNMT1 fragment with
bound substrate DNA
The structural arrangement of the particular domains in
DNMT1 has recently been revealed by several crystallo-
graphic studies (29,43,46–48) (Figure 2). In summary, these
studies demonstrated that the various domains in the N-
terminal part of DNMT1 surround and contact the C-
terminal catalytic domain, indicating that the proper fold-
ing of the catalytic domain likely requires its N-terminal
domains. Unexpectedly, the crystal structures also revealed
that the enzyme undergoes large domain rearrangements,
which allosterically regulate its catalytic activity (Figure 2).
A C-terminal fragment of DNMT1 comprising the BAH
domains and the catalytic domain showed an open con-
formation of the catalytic center, in which the enzyme was
able to bind and methylate substrate DNA (29) (Figure
2A). The elucidation of this complex structure represented
a breakthrough in the field, as it provided the first ex-
ample of a mammalian DNMT structure solved with its
substrate DNA bound in the active site. It confirmed that
the C-terminal domain of DNMT1 adopts the canonical
AdoMet-dependentMTase fold. As expected, it showed the
target base flipped out of the DNA helix and bound to the
enzyme in a manner reminiscent of other DNA MTases.
Moreover, several contacts of the enzyme to the target CpG
site were identified, which were confirmed in kinetic stud-
ies as essential for enzymatic activity and recognition of the
CpG site (49). The BAH1 and BAH2 domains of the mouse
DNMT1 (mDNMT1) are connected by an -helix and are
arranged in a dumbbell like manner on the left and right
side of the catalytic domain. Despite low sequence conser-
vation, both BAH domains adopt a common distorted bar-
rel structure comprising a mixture of 10 parallel and an-
tiparallel -strands and one helix. The close contacts be-
tween the BAH domains and the catalytic domain suggest
that the isolated catalytic domain would probably be mis-
folded, which explains why it is catalytically inactive in an
isolated form (50,51).
As mentioned above, DNMT1 shows a preference
for hemimethylated DNA as compared to unmethylated
substrates, supporting its role as maintenance MTase
(29,44,49–50,52). Its intrinsic preference for hemimethy-
lated DNA has been estimated to about 30- to 40-fold
(53), but it largely depends on the exact substrate sequence,
its length and the reaction conditions. Mechanistically, the
specificity of DNMT1 is mediated by the binding of the
methyl group of the hemimethylated CpG site into a hy-
drophobic pocket in the C-terminal domain of the methyl-
transferase formed by C1501, L1502, W1512, L1515 and
M1535, which favors the binding of hemimethylated CpG
sites (29). Further details of this process and eventual con-
formational changes after binding to an unmethylated CpG
site could only be uncovered, if a structure of DNMT1 with
an unmethylated DNA bound to the active center became
available. The recognition of the 5mC-G base pair is further
mediated byM1535, K1537, Q1538 andR1237, which form
side-chain and backbone H-bonds to the edges of the base
pair in the major and minor groove (29). These interactions
explain why the 5mC and the corresponding G in the tar-
get DNA strand are very accurately recognized by DNMT1
and cannot be exchanged by other nucleotides (49).
Moreover, the DNMT1 structure with DNA bound in
the active center also uncovered additional unforeseen rear-
rangements in the DNMT1–DNA structure, including the
formation of a non-Watson–Crick base pair of the orphan
G residue with a G flanking the CpG site. The (then or-
phaned) C of the flanking G:C base pair was rotated out of
the DNA helix in a direction roughly opposite to the target
C flipping. However, kinetic experiments could not provide
evidence for this reshuffling of base pairs and the double
base flipping (49), suggesting that this structure may still
not capture the true transition state of the methylation re-
action.
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Figure 2. Structures of DNMT1 with different N-terminal domains. The RFT, CXXC, BAH1, BAH2 and catalytic domains are shown in dark green,
red, orange, purple and blue, respectively. (A) DNMT1 in an active conformation with DNA (light green) bound in the active site (29). Removal of the
autoinhibitory RFTD can be triggered by UHRF1 (40,41). (B) DNMT1 with unmethylated DNA bound to the autoinhibitory CXXC domain (43). (C)
DNMT1 with the RFT domain blocking access to the active site (46).
DNMT1 structures reveal allosteric control of its activity
The structure of a larger DNMT1 C-terminal fragment
additionally containing the CXXC domain was solved in
complex with an unmethylated DNA. Unexpectedly, the
DNA did not bind to the catalytic domain, but a CpG
site-specific DNA binding to the CXXC domain was ob-
served (43) (Figure 2B). The CXXC domain of mDNMT1
adopts a crescent-like structure. It contains two short he-
lical segments that bind two zinc ions; each of them is co-
ordinated by four conserved cysteine ligands provided by
two CGXCXXC motifs and two distal cysteine residues.
The CXXC domain binds DNA by approaching the ma-
jor groove, with the protein located perpendicularly to the
DNA axis. This allows a loop segment (consisting of R684-
S685-K686-Q687) to form base-specific contacts and phos-
phodiester interactions that contribute to the recognition of
an unmethylated CpG site (43).
This observation led to the proposal that the CXXC
domain of DNMT1 might have an autoinhibitory func-
tion and that it would act as a specificity filter by prevent-
ing unmethylated DNA from accessing the active site. Ki-
netic experiments with the truncated DNMT1 used for the
structural analysis indeed revealed a clear influence of the
CXXC domain on the specificity of DNMT1 (43). Surpris-
ingly, similar experiments conducted with the full-length
DNMT1 did not provide evidence for a role of the CXXC
domain in the specificity of DNMT1 (44), indicating that
the presence of additional domains may influence the do-
main arrangement. Further experiments are needed to re-
solve this interesting discrepancy.
Finally, another crystal structure of an almost complete
DNMT1 fragment, including the RFT domain but without
DNAwas solved (46) and the structure of the isolated RFT
domain has been obtained as well (47). The RFT domain
consists of a zinc-binding motif, followed by a six-stranded
-barrel and a helical bundle, consisting of five closely as-
sociated alpha helices (47). The DNMT1 structure contain-
ing the RFT domain provided additional seminal insights
into the mechanism of DNMT1, because unexpectedly, it
showed that the RFT domain is deeply inserted into the
DNA-binding pocket of the catalytic domain, thereby in-
hibiting the enzyme (46) (Figure 2C). The autoinhibitory
binding of the RFT domain to the catalytic domain is stabi-
lized by several hydrogen bonds between both protein parts
and ionic interactions between the negative electrostatic po-
tential of the RFT domain and the positive potential of the
DNA binding site in the catalytic domain (46). Autoinhibi-
tion of the activity ofDNMT1by theRFTdomainwas con-
firmed in biochemical studies (46,47). Interestingly, engi-
neering of this interface led to an alteration of the DNMT1
conformation, generating a methyltransferase that was hy-
peractive in vitro and in cells (54).
Mechanism of DNMT1
Several in vitro studies have shown that DNMT1 is a
highly processive enzyme, able to methylate long stretches
of hemimethylatedDNAwithout dissociation from the sub-
strate (52,55–56). During processive methylation, methyl
groups are introduced only in one strand of theDNA,which
indicates that DNMT1 does not exchange DNA strands
while moving along its substrate (55). Due to its high pro-
cessivity, DNMT1 is a very effective enzyme, ideally suited
to follow DNA replication and methylate the newly syn-
thetized DNA strand before the chromatin is reassembled.
The structure of DNMT1 with bound substrate DNA (29)
showed that the enzyme enwraps the DNA, which enables
it to slide along the substrate and catalyze several successive
methylation reactions without dissociation from the DNA.
Therefore, the ability of DNMT1 to adopt open and closed
conformations might not only be involved in the regulation
of its activity, but also of its processivity, because the ability
of the enzyme to adopt a closed conformation after DNA
binding may help preventing its dissociation from the DNA
and thereby increase the processivity.
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Allosteric regulation and targeting of DNMT1 by interacting
partners
As described above, accumulating experimental evidence in-
dicates that the autoinhibitory mechanism of the RFT do-
main plays a central role as an allosteric trigger in DNMT1
(Figures 2 and 3). The flexible arrangement of different do-
mains in DNMT1 is controlled by linker regions, which
form interactions with surface clefts of the domains. Both
the linkers and the surface clefts are subject to many PTMs
in DNMT1, including phosphorylation, acetylation and
ubiquitination, whichmight directly control the positioning
of these domains in DNMT1 (Figure 4). Moreover, binding
of individual domains to various interacting partners has
been shown to alter the domain arrangement and the activ-
ity of DNMT1.
The DNMT1–PCNA interaction. The sub-nuclear local-
ization of DNMT1 changes dynamically during the cell cy-
cle (3,21). It is diffusely distributed in the nucleus during
interphase when cells are not replicating, but in the early
and mid S-phase DNMT1 localizes to the replication foci
in cells actively synthesizing DNA, creating a characteris-
tic punctuate pattern. The targeting of DNMT1 to replica-
tion foci during S-phase is mediated by the PCNA binding
domain (37), the replication foci targeting domain (25) and
the BAH domains (57) (Figure 3). Through the PBD do-
main,DNMT1 directly interacts with PCNA, the processiv-
ity factor of the DNA replication machinery (24). DNMT1
and PCNA co-localize in vivo, indicating that PCNAmight
recruit DNMT1 to the replication fork and load it onto
DNA. Indeed, expression of a truncated DNMT1, which
lacks parts of the PBD domain, led to a delay in the re-
methylation of DNA after replication (38). However, it did
not cause massive defects in DNA methylation, indicating
that the interaction of PCNA with DNMT1 contributes to
the efficiency of DNA re-methylation, but is not indispens-
able for this process. In addition, in vitro experiments pro-
vided evidence that the interaction with PCNA increases
DNA binding and catalytic activity of DNMT1, suggest-
ing that it may also exert allosteric effects on the catalytic
domain (58).
During progression of the S-phase, the sub-nuclear pat-
tern of DNMT1 localization changes from small, punc-
tuate and abundant structures in early S-phase to fewer,
large, toroidal structures in late S phase, which co-localize
with the late-replicating heterochromatic satellite DNA
(24–25,59), and someDNMT1 remains associatedwith cen-
tromeric heterochromatin in the late S and G2 phases, even
after heterochromatin replication. The interaction with het-
erochromatin is mediated by the PBD domain of DNMT1
in a replication-independent manner (24) and it is also at
least in part mediated by the interaction of DNMT1 with
UHRF1, as described in the next section.
The DNMT1–UHRF1 interaction. Another pathway of
DNMT1 targeting was discovered about 10 years ago with
the finding that UHFR1 is required for the maintenance
of DNA methylation in mammals (60,61). UHRF1 specifi-
cally binds to hemimethylated DNA via its SET and RING
associated (SRA) domain (60,62–64) and its localization
to replicating heterochromatin is dependent on the pres-
ence of hemimethylated DNA (61). UHFR1 co-localizes
with DNMT1 and PCNA at replicating heterochromatic
regions during mid to late S-phase and the association of
DNMT1 with chromatin is lost in UHFR1 knockout (KO)
cells (60,61). Remarkably, the phenotype of the UHFR1
KO in mice mimics that of the DNMT1 KO, as UHRF1-
deficient embryos die shortly after gastrulation and show
significantly reduced levels of DNA methylation genome-
wide (61), indicating that UHRF1 has an essential role
in the maintenance of DNA methylation. These observa-
tions led to a model that UHFR1 recruits DNMT1 to
replicated hemimethylated DNA to facilitate its efficient re-
methylation (65) (Figure 3).
Later, it was found that UHRF1 is part of a complex
chromatin interaction network (Figure 3) and two addi-
tional domains of UHRF1, the tandem Tudor domain
(TTD) and the plant homeodomain (PHD) further con-
tribute to the maintenance of DNA methylation. TTD
binds histone 3 tails methylated at lysine 9 (H3K9me3) and
unmethylated at lysine 4 (66,67), whereas the PHD domain
binds to H3 tails unmodified at arginine 2 (H3R2) (68–
70). The interaction with H3K9me3 is required for the lo-
calization of UHRF1 to heterochromatin and for mainte-
nance DNA methylation, since a mutation in TTD, which
prevents binding of UHRF1 to H3K9me3, abolished both
functions (66,67). Similarly, disruption of H3R2 binding
abolishedDNAmethylation byDNMT1 in cells (71). These
data indicate that the coordinated recognition of two his-
tone marks, H3K9me3 and H3R2, by UHRF1 as well as
its interaction with hemimethylated DNA are all necessary
for guidance of DNMT1 to DNA and subsequent mainte-
nance of DNA methylation patterns (72,73). Recently, the
central role of the H3K9me2/UHRF1/DNMT1 axis in the
control of DNAmethylation has also been demonstrated in
the differentiation of ES cells (74).
In line with the general model of combined targeting and
allosteric activation of DNMTs by interactors proposed
here, UHRF1 was also shown to directly stimulate the cat-
alytic activity of DNMT1, by interacting with the RFT do-
main of the MTase and relieving the auto-inhibition medi-
ated by this domain (40,41). Moreover, the RING domain
of UHRF1 has been shown to ubiquitinate H3 at K18 and
K23 (71,75). Ubiquitinated H3 is bound by DNMT1, lead-
ing to the stimulation of its methyltransferase activity. Fi-
nally, UHRF1 is involved in the ubiquitination of DNMT1
that reduces DNMT1’s stability (see below). All these ob-
servations demonstrate that UHRF1 is a multifaceted reg-
ulator of DNMT1 activity, targeting and stability (Figure
3). Interestingly, a structural and biochemical study has
shown thatUHRF1 also employs a domain conformational
change triggered by binding of hemimethylated DNA to
enhance H3K9me3 binding (76), indicating that conforma-
tional changes dictate the behavior of different subunits of
chromatin complexes.
Binding of the DNMT1–RFTD to H3-ubiquitination. Re-
cent studies demonstrated the role of histone H3 ubiqiti-
nation in DNMT1 function. DNMT1 associates with the
ubiquitylated H3 through its RFT domain and this interac-
tion contributes both to the targeting of DNMT1 to repli-
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Figure 3. Regulatorymechanisms controlling the activity, targeting and stability of DNMT1. The figure illustrates the complex interplay betweenDNMT1,
UHRF1, USP7, PCNA and chromatin. Enzymatic activities are indicated by arrows. Binding (‘reading’) interactions are symbolized by dotted lines. For
details cf. the text.
Figure 4. Representation of posttranslationalmodifications (PTMs) found
in human DNMT1 on the structure of murine DNMT1 (46). Phosphory-
lations, acetylations, methylations and ubiquinations retrieved from Phos-
phosite Plus are represented by red circles labeled with P, A, M or U, re-
spectively. The DNMT1 domains are colored as in Figure 2C.
cation foci and to the activation of the enzyme (71,75), pro-
viding yet another example of a concerted regulation of
multiple aspects of DNMT’s function. The ubiqitination
of the H3 tail is introduced through the E3 ligase activ-
ity of the UHRF1 RING domain (71,75). Ubiquitination
has been observed at K18 and K23 of H3, and also on
DNMT1 itself, but it is unclear at present how these findings
are related. These data highlight another important con-
nection between the DNMT1 and UHRF1-mediated chro-
matin interactions, which is essential for an efficient main-
tenance methylation to occur (Figure 3). Whether confor-
mational changes of DNMT1 are involved in this process is
not known at present.
The DNMT1–USP7 interaction. Several studies showed
that Ubiquitin-specific protease 7 (USP7), also known
as Herpes virus-associated ubiquitin-specific protease
(HAUSP), binds to DNMT1 and increases its stability
through deubiquitination (77–79) (Figure 3). DNMT1 and
USP7 form a stable, soluble complex that associates with
UHRF1 as a trimeric complex on chromatin (78). The
crystal structure of a human DNMT1 fragment starting
with the CXXC domain in complex with USP7, but with-
out DNA revealed that the interaction of both proteins
is mainly mediated by the KG linker of DNMT1 and an
acidic pocket near the C-terminus of USP7. Mutations of
these acidic residues in USP7 and acetylation of the lysine
residues of the KG linker in DNMT1 disrupted the inter-
action between DNMT1 and USP7, leading to increased
proteasomal degradation of DNMT1 (80). Interestingly,
binding of USP7 also increased the activity of DNMT1 in
vitro (78), indicating that USP7 acts as a general positive
factor of DNMT1, by increasing the stability and activity
of the methyltransferase. It is currently unknown, whether
USP7 binding affects the autoinhibition of DNMT1
by the N-terminal domain. While no conformational
changes were observed in the structure of USP7 bound
to a DNMT1 fragment starting with the CXXC domain
(80), the binding of USP7 to the KG linker region suggests
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that it might restrict the ability of the full-length DNMT1
to adopt certain conformations in solution. In addition,
USP7 deubiquitinates other chromatin-associated proteins,
including histone H2B and the histone acteyltransferase
Tip60, and it prevents autoubiquitinylation of UHRF1,
which increases its stability (78), indicating that USP7 plays
an important general role in epigenetic regulation (81).
Regulation of activity and specificity of DNMT1 by nucleic
acid binding
DNMT1 contains multiple DNA binding sites, which con-
tribute to the allosteric regulation of its activity and speci-
ficity. Several early studies showed that the enzyme has
reduced specificity in the presence of methylated DNA
(50,82–85). This effect was due to an increase in the methy-
lation rate of of unmethylated DNA, while the methyla-
tion of hemimethylated DNAwas weakly inhibited (50,52).
These data suggest that binding of the methylated DNA to
the N-terminal part of the enzyme induces an allosteric ac-
tivation and relaxation of specificity, which stimulate the
methylation of unmethylated DNA. However, the molec-
ular mechanism of this allosteric activation of DNMT1
is currently unknown; the CXXC domain (50) and the
residues 284–287 of the murine DNMT1 (85) have been im-
plicated in it, suggesting that DNA binding to the CXXC
domain may mediate the effect. In addition, a general in-
hibitory effect of unmethylated DNA on DNMT1 was
demonstrated in several studies (84,86–87). The binding site
for this substrate inhibition effect was localized within the
first 501 amino acids of DNMT1 (88). Additional evidence
suggests that binding ofmethylatedDNA to theN-terminal
inhibition site also causes de-repression of the enzyme (88).
Whether these various inhibition and stimulation effects are
due to binding to the same or different sites and to what ex-
tend different DNAs compete for the different sites is not
clear. Moreover, the involvement of direct binding of these
DNAs to the catalytic domain can also not be excluded.
Interestingly, many studies found that binding of
DNMT1 to unmethylated DNA at an allosteric site reduces
its activity, while binding to methylated DNA increases it.
This observation could be related to the bimodal nature
of DNA methylation patterns found in the human genome
that mainly comprises highly methylated or completely un-
methylated regions (89–91). Propagation of such bimodal
methylation patterns is supported by the allosteric binding
of DNA to secondary sites in DNMT1, because DNMT1
would be activated on methylated regions and inactivated
on unmethylated DNA, which would lead to a further gain
of methylation at highly methylated regions and loss of
methylation at lowly methylated regions.
Besides DNA, DNMT1 is able to bind to different non-
coding RNAs. Initial studies revealed that DNMT1 puri-
fied from insect cells contained inhibitory RNA (92). Later,
it was discovered that RNA binding regulates the activity
of DNMT1 in a locus specific manner (93). A long non-
coding RNA (ncRNA) originating from the CEBPA locus
was shown to bind and inhibit DNMT1, and prevent the
methylation of this locus. Similar effects were observed for
several other loci on the genomic level (93). Based on these
findings, the authors proposed a model, in which the ncR-
NAs transcribed at one locus shield this locus from methy-
lation. Thereby, the expression of the locus would be am-
plified, causing a positive feedback loop that keeps the lo-
cus unmethylated and transcriptionally active. Recently, it
was also reported that DNMT1 binds tomicroRNAs (miR-
NAs), like miR-155-5p (94). Similarly to the long ncR-
NAs, miRNAs function as inhibitors of DNMT1 and the
transfection of miRNAs into cells influences cellular DNA
methylation (94). RNAbinding wasmapped to the catalytic
domain of DNMT1 (93,94), and the miRNAs were shown
to act as DNA competitive inhibitors (94), suggesting that
the inhibition of DNMT1 by RNAs is based on a direct
competition between the RNA and the substrate DNA for
access to the catalytic center. However, it is also conceiv-
able that the additional DNA binding sites described above
could bind regulatory RNAs, leading to allosteric effects.
Hence, important features of the interaction of DNMT1
with regulatory DNA and RNA are not yet understood at
a molecular level and deserve further attention.
Regulation of DNMT1 by PTMs
DNMT1 undergoes several PTMs, including phosphoryla-
tion, methylation, ubiquitination, acetylation and sumoy-
lation. Following the initial identification of serine 515 as
a major phosphorylation site in murine DNMT1 purified
from insect cells (95), several phosphorylated serine, threo-
nine and tyrosine residues have been identified in targeted
and high-throughput proteomics approaches with DNMT1
purified from human cells. Currently, more than 100 PTM
sites have been mapped on human and mouse DNMT1
(http://www.phosphosite.org) (Figure 4). They localize to
the crucial parts of the methyltransferase: on the surfaces of
the DNMT1 domains, where they can influence the interac-
tion with other proteins, in the linker regions connecting the
domains, where they can directly affect the conformation of
the enzyme, and in the catalytic domain, where they might
directly regulate activity.
Unfortunately, only few of the DNMT1 PTMs have been
functionally studied. The phosphorylated S515 in murine
DNMT1 is involved in the interaction between the N-
terminal and catalytic domains of DNMT1 and is nec-
essary for the activity of the enzyme (96). Phosphoryla-
tion of S146 in the human enzyme introduced by casein
kinase 1 delta/epsilon decreases the DNA binding affin-
ity of DNMT1 (97), whereas phosphorylation of S127 and
S143 regulates the interaction of DNMT1 with PCNA and
UHRF1 (98). The S143 of DNMT1 is phosphorylated by
AKT1, which leads to the stabilization of the methyltrans-
ferase (99). Recently, a specific 14-3-3 family reader pro-
tein for this modification was identified (100). It binds to
the phosphorylated DNMT1, leading to the inhibition of
DNMT1 activity in vitro and in cells, and subsequent aber-
rant DNA hypomethylation (100). Finally, phosphoryla-
tion of DNMT1 by protein kinase C (PKC) has been re-
ported, but the target sites have not yet been identified (101).
The functional significance of many other phosphoryla-
tions in DNMT1 still needs to be elucidated and, in particu-
lar, the influence of the PTMs on the allosteric regulation of
DNMT1 activity, specificity and localization deserves fur-
ther attention.
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Multiple acetylation sites have been identified on
DNMT1 up to date in proteomics analyses (102–104) (http:
//www.phosphosite.org); however, their functional signifi-
cance has only begun to be revealed. Initial experiments
with deacetylase inhibitors demonstrated the involvement
of acetylation in the control of DNMT1 stability (104,105).
Recently, an elegant mechanism regulating the abundance
of DNMT1 during cell cycle has been identified. It starts
with the acetylation of the lysine residues in theKG linker of
DNMT1 catalyzed by the acetyltransferase Tip60 (77,79).
KG acetylation leads to the UHRF1-mediated ubiquitina-
tion of DNMT1, resulting in its proteasomal degradation
at the end of DNA replication. In turn, histone deacetylase
1 (HDAC1) increases the stability of DNMT1 (77,79). This
effect is meditated by the deacetylation of theKG linker, fol-
lowed by binding of the USP7 deubiquitinase to DNMT1,
which prevents its ubiquitination (80). In addition, SIRT1
deacetylates DNMT1 at several sites and thereby regulates
the activity and function of the methyltransferase as well
(104).
The first described example of lysine methylation on
DNMT1 was the monomethylation of K142 by SET7/9,
which occurs mainly during late S-phase and promotes
proteasomal degradation of the methyltransferase in a cell
cycle-dependent manner (106). The methylation level is
higher in the absence of the LSD1 lysine demethylase, sug-
gesting that methylation of DNMT1 is reversible (107). In
addition, as K142 is located directly next to S143, its methy-
lation is antagonistic with the AKT1 mediated phosphory-
lation of S143 described above (99). This phospho-methyl
switch is yet another example of the complex mechanisms
that have evolved to fine-tune the function of DNMT1.
We anticipate that many more examples of the crosstalk
of DNMT1 PTMs will be discovered in the future. PTMs
are ideally suited to mediate regulation of DNMT1 func-
tion, including either direct effects occurring through con-
formational changes of DNMT1 or by recruiting modifica-
tion specific readers. Via both pathways, critical properties
of the enzyme could be regulated, including enzyme stabil-
ity, targeting, interaction with other proteins or its catalytic
properties, like the overall activity, processivity and eventu-
ally specificity.
In summary, while we have already learned a lot about
the structure and mechanism of DNMT1, there are still
gaps in our understanding of its allosteric regulation, be-
cause all currently available structures of DNMT1 were ob-
tained with truncated proteins, therefore, they might not
represent the exact domain arrangement in the full-length
enzyme. In addition, structures of posttranslationally mod-
ified DNMT1 are currently unavailable, and full-length
DNMT1 structures in complex with interacting proteins are
missing, raising the possibility that additional and perhaps
even more complicated allosteric control effects might be
discovered in the future. Moreover, as mentioned above, the
thorough understanding of the atomic details of the recog-
nition of the hemimethylated DNA awaits the availability
of a structure containing an unmethylated substrate DNA
and subsequent molecular dynamics simulations.
STRUCTURE, MECHANISM AND REGULATION OF
DNMT3 ENZYMES
Domain composition of DNMT3 enzymes
The DNMT3 family comprises three paralogues,
DNMT3A, DNMT3B and DNMT3L, which all share con-
siderable sequence similarity (Figure 1). Several isoforms
of DNMT3A and DNMT3B, resulting from alternative
splicing or use of alternative start codons have been identi-
fied both in mouse and human cells (3). Like DNMT1, the
DNMT3 proteins contain a C-terminal domain, which in
the case of DNMT3A and DNMT3B contains the active
center, and an N-terminal domain involved in the targeting
of the enzymes to chromatin and regulation of their func-
tion (3). In the N-terminal part, two functional domains are
present, the ADD (ATRX-DNMT3-DNMT3L) domain
and the PWWP domain, which is missing in DNMT3L.
The ADD domain comprises three subdomains
(108,109). The first subdomain contains four Cys residues,
which bind a Zinc ion and form a GATA-like zinc finger.
The second subdomain binds two zinc ions with eight
Cys residues and forms a PHD finger with a cross-braced
topology that is packed against the GATA-like finger.
Finally, a long C-terminal -helix that runs out from the
PHD finger makes extensive hydrophobic contacts with
the N-terminal GATA finger. The ADD domains mediate
the interaction of all three DNMT3 proteins with histone
H3 tails unmethylated at lysine K4 (110–113), similarly
as in ATRX (114). In addition, this domain is involved
in the interaction of DNMT3A with various components
of the epigenetic machinery. Notably, the ADD domain
has recently been implicated in the allosteric control of
DNMT3A (see below), indicating that ADD-mediated in-
teractions with other proteins could have direct regulatory
effects on the catalytic activity of the MTase.
The PWWP domain of DNMT3A and DNMT3B is a
conserved region of 100–150 amino acids, containing a
characteristic proline–tryptophan motif (hence the name
PWWP). PWWP domains belong to the Royal domain
super-family, members of which interact with histone tails
in various modification states (115). The structures of the
PWWP domain from both DNMT3A and DNMT3B have
been solved (116,117) and showed that it is divided into an
N-terminal -barrel, consisting of five antiparallel strands
and a C-terminal helical bundle composed of five helices.
The PWWP motif, which is a part of the -barrel, is lo-
cated at the interface of the two substructures (116). The
PWWP domains of DNMT3A and DNMT3B specifically
recognize theH3K36 trimethylationmark (118,119) and are
essential for the targeting of the enzymes to pericentromeric
chromatin (16,17). It has been suggested that the PWWP
domain of DNMT3 enzymes would synergistically bind the
H3K36me3 histone tail and theDNA through its conserved
aromatic cage and a positively charged surface, respectively
(115–117).
The part of DNMT3A and DNMT3B N-terminal to the
PWWP domain is the least conserved region between both
enzymes. Consequently, this partmay be responsible for tar-
geting of the enzymes to different genomic loci. This do-
main binds DNA (120) and is important for anchoring of
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the enzymes to nucleosomes (18,119). However, up to date
no specific molecular or biological function has been as-
signed to this part.
The C-terminal domains of all three DNMT3 proteins
adopt the typical AdoMet-dependent MTase fold. The C-
terminal domains of DNMT3A and DNMT3B share 81%
sequence identity and contain the catalytic centers of the
enzymes. The C-terminal domain of DNMT3L also shares
clear homology with the other family members, but it con-
tains several amino acid exchanges and deletions within
the conserved DNA-(cytosine C5)-MTase motifs, indicat-
ing that DNMT3L cannot have catalytic activity and it is
unable to bind AdoMet. In contrast to the catalytic do-
main of DNMT1, the catalytic domains of DNMT3A and
DNMT3Bare active in an isolated form (121) and have been
used asmodel systems to study the catalytic mechanism and
specificity of the DNMT3 proteins. Interestingly, the iso-
lated catalytic domains of DNMT3A and DNMT3B show
higher enzymatic activity than the full-length proteins, in-
dicating that the N-terminal domains allosterically inhibit
the activity of the enzymes (122), similarly as observed for
DNMT1. Furthermore, kinetic experiments showed that
binding of the ADD domain of DNMT3A to H3 tail pep-
tides stimulates the activity of the enzyme (112–113,122).
The molecular explanation for both these observations was
provided recently by a seminal structural and biochemical
study showing that the ADD domain of DNMT3A directly
interacts with the catalytic domain of the methyltransferase
and exerts an autoinhibitory function in the absence of his-
tones (see below) (113) (Figure 5).
Tetrameric structure of the DNMT3A/DNMT3L C-
terminal complex
Up to date, structures containing truncated DNMT3A–
DNMT3L complexes (113,123) and one structure of full-
length DNMT3L (110) have been solved. In addition, the
structures of the isolated ADD and PWWP domains in
a free and peptide-bound form are available (111,116–
117). The structure of the complex of the C-terminal do-
mains of DNMT3A/DNMT3L was solved in 2007, be-
ing the first published structure of a mammalian DNMT
(123). It showed that the complex forms a linear heterote-
tramer consisting of two DNMT3L subunits (at the edges
of the tetramer) and two DNMT3A subunits (in the cen-
ter) (123) (Figure 5). The heterotetrameric structure of the
complex was confirmed in solution (124). The structure re-
vealed that the C-terminal domain of DNMT3A contains
two interfaces for protein–protein contacts: a hydrophobic
one generated by the stacking interaction of two pheny-
lalanine residues (called FF interface), which mediates the
DNMT3A/DNMT3L interaction, and a polar one stabi-
lized by a hydrogen bonding network between arginine and
aspartate residues fromboth subunits (calledRD interface),
which mediates DNMT3A/DNMT3A interaction. In con-
trast, DNMT3L contains only the FF interface since the re-
gion corresponding to the RD interface is absent. Residual
electron density of the DNA ligand observed in the struc-
ture analysis and biochemical studies using interface mu-
tants demonstrated that the central DNMT3A/DNMT3A
interface creates the DNA binding site, while both inter-
faces are essential for AdoMet binding and catalytic activ-
ity (123,124). The dimerization of DNMT3A via the RD
interface increases the size of the DNA interface and may
therefore compensate for the small TRD of DNMT3A.
The spacing of the two active centers facing the DNA
at the RD interface predisposes DNMT3A to optimally
methylate CpG sites present in a distance of ∼10 bps. In-
deed, in vitro methylation experiments demonstrated that
there is a correlation of methylation between CpG sites lo-
calized ∼10 bps apart (123,124). Interestingly, an enrich-
ment of CpG sites in such distance was observed in the
differentially methylated regions (DMRs) of 12 maternally
imprinted mouse genes, which are known biological sub-
strates of the DNMT3A/DNMT3L complex, suggesting
that the favorable CpG spacing could make these sequences
good substrates for the MTase complex (123). Later, a 10
bps periodicity of methylation densities was observed in
genome-widemethylation studies in human and plantDNA
(91,125–128), suggesting that it represents a general pattern
of genomic DNA methylation. Chodavarapu et al. (2010)
proposed that this pattern might reflect limitations of the
access to the DNA by nucleosomes due to the alternating
exposure of the minor and major groove of the nucleoso-
mal DNA with the same periodicity (127). However, none
of these models to explain the 10 bp periodicity is flaw-
less, because on one hand, the enzyme(s) potentially respon-
sible for the 10 bps methylation periodicity in plants are
not known, and on the other hand, the 10 bp periodicity
was also observed outside of the nucleosome in the linker
DNA. Hence, additional work is needed to further investi-
gate these fundamental processes.
DNMT3A structures revealing allosteric control of its activ-
ity
Recently, new structures of a longer DNMT3A C-terminal
fragment including the ADD domain in complex with the
C-terminal domain of DNMT3L have been solved (113).
They made an additional seminal contribution to our un-
derstanding of the mechanism of this enzyme by showing
that the ADD domain can bind to the catalytic domain at
two distinct sites, an allosteric one and an inhibitory one,
creating two alternative conformations. ADD binding to
the allosteric site keeps the enzyme active, while its bind-
ing to the inhibitory site blocks access of the DNA to the
active center and inhibits catalysis (113) (Figure 5). These
data indicate that the catalytic activity of DNMT3A, like
that of DNMT1, is under allosteric control by rearrange-
ments of its N-terminal domains, illustrating a fascinating
convergence of the regulatory mechanisms of these two en-
zymes. Similarly as in DNMT1, protein partners and PMTs
can influence the equilibrium of the active and inactive con-
formations. For example, the stimulatory effect of H3 on
DNMT3A depends on its binding to the ADD domain,
leading to the stabilization of the ADD at the allosteric
binding site (see below) (113,122).
Specificity of DNMT3 enzymes
Consistent with their designation as de novo MTases,
DNMT3A and DNMT3B do not discriminate between
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Figure 5. Structure and allosteric regulation of DNMT3A. The picture shows the structure of the DNMT3A/3L heterotetramer (123). The ADD domain
of the dark blue DNMT3A subunit is shown in the autoinhibitory conformation (orange) and in the catalytically active allosteric conformation (red) (113),
the ADD domain of the cyanDNMT3A subunit has been omitted for clarity. Binding of the H3 peptide (purple) to the ADD domain occurs by interaction
with residues, which are involved in the autoinhibitory-binding interface. Therefore, peptide binding is only possible in the active conformation and this
conformation is consequently stabilized in the presence of the H3 peptide (113,122).
hemimethylated and unmethylated DNA substrates. Al-
though both enzymes methylate cytosine residues predom-
inantly in the context of CpG dinucleotides, they can also
introducemethylation in a non-CpG context with an appar-
ent preference for CA >> CT > CC; and methylation rates
at non-CpG sites can be as high as 50% of the rates at CpG
sites (15,129–130). In contrast, the non-CpG methylation
rates of DNMT1 are much lower (below 0.5% of what is
observed with hemimethylated CpG sites) (49–50), indicat-
ing that the non-CpG methylation directly reflects the ac-
tivity of DNMT3 enzymes. Consistently, methylated non-
CpG sites are widespread in embryonic stem (ES) cells and
brain, where DNMT3A and DNMT3B enzymes are highly
expressed, but not in cells where DNMT3 enzymes are ex-
pressed only at low levels (126,131–133). However, a re-
cent study revealed the presence of non-CpG methylation
at lower levels in almost all human tissues (134), indicat-
ing that DNMT3 activity is indeed present in most tissues
and it contributes to the overall DNAmethylation patterns.
Studies with different DNMT KO cell lines also confirmed
that DNMT3 enzymes introduce non-CpG methylation in
cells (135,136). A first glimpse into the biological role of
non-CpG methylation was provided recently with the ob-
servation that non-CpG methylation can recruit MeCP2
(133,137–138), disruption of which is implicated in the Rett
syndrome and that this process is involved in the repression
of long genes in the brain (137).
In addition to their preference for the methylation of
CpG sites, both DNMT3A and DNMT3B are very sensi-
tive to the sequences flanking their target sites. This is il-
lustrated by the finding that CpG sites embedded in certain
flanking sequences cannot be methylated by DNMT3A at
all (139). It has been shown that purine bases are preferred
at the 5′ end of the CpG sites, whereas pyrimidines are fa-
vored at their 3′ end (139–141). Interestingly, experimental
flanking sequence preferences of DNMT3A andDNMT3B
correlate with the statistical data on the methylation level of
CpG sites found in the human genome (91,141), suggesting
that the inherent sequence preferences of de novo enzymes
contribute to the selection of genomic regions that undergo
methylation. One further consequence of the strong flank-
ing sequence preferences of DNMT3A and DNMT3B is
that both DNA strands of a CpG site, which are embedded
in an asymmetric flanking sequence context, usually differ
strongly in their ability to undergomethylation byDNMT3.
This leads to the preferential methylation of one strand
by the DNMT3 enzymes, generating hemimethylated prod-
ucts. Consistently, hemimethylated sites were detected in ES
cells (136). In vitro experiments demonstrated that the prod-
ucts of DNMT3Amethylation can be readily methylated by
DNMT1 and both enzymes act synergistically to promote
efficient de novo methylation of unmethylated DNA (82).
A deeper mechanistic understanding of the non-CpG
recognition and flanking sequence preferences of DNMT3
enzymes awaits the availability of structures of DNMT3 en-
zymes with bound substrate DNA. An initial mutational
analysis of residues in the (at that time putative) DNAbind-
ing site of DNMT3A showed that exchanges of critical
residues pointing toward the DNA in the structural model
caused massive changes of flanking sequence preferences of
DNMT3A (32). These data confirmed that DNA binding
and recognition is mediated by the cleft formed by the RD
interface. Interestingly, the residues that potentially contact
the DNA include R881, a residue frequently mutated in
AML cancer (9), raising the possibility that this mutation
might affect the DNA interaction of DNMT3A. In addi-
tion, some residues pointing toward the DNA binding cleft
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differ between DNMT3A and DNMT3B, suggesting that
DNMT3A and DNMT3B might differ in their specificity.
Mechanism of DNMT3 enzymes
Initial studies with the C-terminal domains of DNMT3A
and DNMT3B showed an interesting difference in the
catalytic mechanism of both enzymes. While DNMT3B
methylated multiple CpG sites in a processive manner,
DNMT3A was distributive, dissociating from DNA after
each catalytic turnover (121). Later, it was reported that
DNMT3A methylates DNA in a processive manner and
that the processivity is increased by DNMT3L (142). How-
ever, DNMT3A also binds cooperatively to DNA, forming
largemultimeric protein/DNAfibers (123–124,143) (Figure
6B). These properties appear mutually exclusive, because
the concept of a processive turnover is based on isolated
enzyme complexes moving along a DNA substrate, which
is not compatible with protein complexes multimerizing on
DNA. Recent biochemical studies did not detect processive
DNA methylation by DNMT3A (144).
Regulation of DNMT3 enzymes by protein oligomerization
DNMT3 enzymes exhibit a complex oligomerization and
multimerization potential, including two independent or-
thogonal multimerization reactions (145). First, DNMT3A
multimerizes on DNA and binds to it in a cooperative man-
ner (horizontal polymerization), and secondly, DNMT3A
can form protein oligomers able to bind to more than one
DNA molecule (vertical polymerization) (Figure 6).
Multimerization of DNMT3A and DNMT3A/DNMT3L on
DNA. As described above, DNMT3A forms a linear het-
erotetrameric complex with DNMT3L, in which two cen-
tral DNMT3A subunits interacting via the RD interface
generate theDNAbinding site (123,124) (Figure 6A). DNA
binding by DNMT3A is non-specific (143) and coopera-
tive, as confirmed by different methods, including absence
of binding intermediates in gel retardation assays and sig-
moidal binding curves of DNA substrates in solution DNA
binding experiments (123–124,143–144). The cooperative
binding of DNMT3A (and DNMT3A/DNMT3L) com-
plexes next to each other on DNA leads to the formation
of DNMT3–DNA filaments observed by atomic force mi-
croscopy imaging (124,143) (Figure 6B). Interestingly, two
adjacent DNMT3 complexes in such filament can contact
the cytosine residues in the upper and lower DNA strand of
the same CpG site, providing an option for the enzyme to
directly methylate one CpG site in both DNA strands (Fig-
ure 6C). The 10 bps spacing between the two active centers
within the DNMT3 complexes leads to a characteristic pro-
file of DNAmethylation introduced by the DNMT3Amul-
timers on DNA, with peaks observed at distances of 8–10
bps (124).
The interface of adjacent DNMT3A complexes bound
to DNA was mapped to a loop within the putative TRD
of DNMT3A, and mutation of residues within this loop
disrupted multimerization (143). Interestingly, it also led to
the loss of heterochromatic enrichment of DNMT3A, sug-
gesting that cooperative DNA binding and multimerization
of DNMT3A complexes on DNA contribute to the het-
erochromatic localization of the enzyme in cells. Further-
more, recent studies have shown that the cooperative bind-
ing of DNMT3A to long DNA substrates increases the rate
of DNA methylation in vitro (144) and in targeted DNA
methylation experiments in cells (Stepper et al., manuscript
submitted for publication), indicating that it is important
for DNA methylation by DNMT3A.
Cooperative DNA binding of DNMT3A increases its
DNA binding affinity and reduces the rate of dissociation,
which might help anchoring theMTase on DNA, providing
amolecular explanation for its strong binding tomethylated
chromatin (18,19). However, the exact role of the coopera-
tive DNA binding of DNMT3A in live cells needs further
investigation and the sizes of DNMT3A–DNA filaments
in cells are currently unknown. Based on the crystal struc-
ture, one may speculate that binding of up to five DNMT3
protein complexes would be possible in the linker DNA re-
gions of chromatin. This is in agreement with biochemical
data showing preferential methylation of linker DNA by
DNMT3 enzymes in vitro (146–148). Similarly, in vivo stud-
ies showed that DNMT3B expressed in yeast preferentially
methylates linkerDNA (149) and an analogousmethylation
pattern was observed after reintroduction of the DNMT3
enzymes into DNMT3 KO ES cell lines (119). Interest-
ingly, genome-wide methylation studies revealed that DNA
bound to nucleosomes is higher methylated on average than
linker DNA (127). However, in this study methylation lev-
els reflected the steady-state of both the methylation and
demethylation activities, and it is very plausible that nucle-
osome occupancy also reduces the accessibility of the DNA
for DNA demethylation processes. In contrast, in the yeast
study, DNA demethylation activity is absent, therefore, the
observed methylation pattern directly reflects the DNMT
activity.
Longer DNMT3 filaments might form if DNMT3 bind-
ing is coupled to nucleosome remodeling. Consistently,
DNMT3 enzymes form complexes with various chromatin
remodelers, including SMARCA4 (150), CHD4 (151),
hSNF2 (152) and HELLS (153,154). Notably, the interac-
tion with HELLS is essential for de novoDNAmethylation
(155,156). In line with this model, remodeling activity pro-
motes the methylation of nucleosomal DNA (148).
Protein multimerization of DNMT3 enzymes. Aside its
ability to form heterotetrameric complexes with DNMT3L
and to polymerize on DNA, DNMT3A alone can also
form protein filaments (Figure 6D), which can lead to
its reversible aggregation, as observed in different studies
(157,158). This is possible, because the FF interface of the
DNMT3A/DNMT3L tetramer is symmetric, so that it also
supports the interaction of two DNMT3A molecules in
addition to the interaction of DNMT3A with DNMT3L.
Hence, each DNMT3A subunit contains two interfaces for
self-interactions, the RD interface and the FF interface
and the alternative use of both interfaces leads to the for-
mation of linear DNMT3A protein fibers. Notably, addi-
tion of DNMT3L directs the preferential formation of de-
fined DNMT3A/DNMT3L heterotetramers that cannot
oligomerize further, becauseDNMT3L does not contain an
RD interface and therefore functions as a cap in DNMT3
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Figure 6. Multimerization of DNMT3A and DNMT3A/DNMT3L complexes. (A) Structure of the DNMT3A–DNMT3L complex with bound DNA.
(B) Schematic model of multimerization of the DNMT3A/DNMT3L complexes on DNA. (C) Magnification of a part of B showing the access of active
centers of the central DNMT3A subunits to both DNA strands of CpG sites (yellow boxes). (D) Schematic model of DNMT3A protein multimerization
and binding to several DNA molecules. (E) Combination of both multimerization processes leading to the 2D multimerization of DNMT3A.
protein multimerization. As described below, this process
is implicated in the release of DNMT3A from heterochro-
matic sites (157).
Since each RD interface of an DNMT3A oligomer con-
stitutes a potential DNA binding site, the protein oligomers
can bind to more than one DNA molecule, provided that
they are oriented roughly in parallel (157) (Figure 6D),
and a combination of both multimerization reactions could
lead to the formation of two-dimensional (2D) DNMT3–
DNA networks (Figure 6E). The ability to form protein
oligomers plays a central role in the heterochromatin lo-
calization of DNMT3A, as non-oligomerizing DNMT3A
mutants affected at any of the two interfaces lost the ability
to bind to heterochromatin, despite the presence of intact
PWWP and ADD domains. Since heterochromatic DNA is
densely packed, it might provide several DNA strands for
DNMT3A interaction in matching geometry, contributing
to anchoring of DNMT3A to pericentromeric chromatin.
Despite significant progress in dissecting protein multi-
merization of the DNMT3 enzymes, many questions still
await elucidation. For example, based on the sequence sim-
ilarity and the interface conservation, DNMT3B is ex-
pected to self-oligomerize as well, however, the oligomeric
state of DNMT3B is unknown at present. Similarly,
DNMT3A forms catalytically active heterodimers with
DNMT3B that use the same interfaces as described above
for DNMT3A (159). However, the relative affinities for
the self-interactions of DNMT3A and DNMT3B, as com-
pared to the interaction of DNMT3A with DNMT3B at
the two interfaces are unknown. Equally, the relative pref-
erences ofDNMT3A andDNMT3B for bindingDNMT3L
at the FF interface have not been determined, although
the preferential formation of defined heterotetramers of
DNMT3A and DNMT3L suggests that at the FF inter-
face the DNMT3A/DNMT3L interaction is stronger than
the self-interaction of DNMT3A. Finally, the direct proof
for the existence of DNMT3 protein multimers in cells that
are larger than the tetrameric structure observed in the
DNMT3A/DNMT3L complex still needs to be provided.
Targeting and regulation of DNMT3 enzymes by direct chro-
matin interaction
The ADD and the PWWP domains located in the N-
terminal part of DNMT3 proteins were shown to target
the MTases to chromatin carrying defined modifications.
When combined with the DNA binding through DNMT3
multimerization, a multivalent interaction of the DNMT3
enzymes with chromatin occurs, which may explain the ex-
traordinarily strong binding of these enzymes to nucleoso-
mal heterochromatic DNA (18,19).
Binding of the DNMT3 ADD domain to H3 tails. In 2007,
binding of the H3 tails to the ADD domain of DNMT3L
was described, a seminal discovery showing for the first
time the direct targeting of a DNMT to chromatin via
histone tail interactions (110). Today, it is clear that the
ADDdomains of all threeDNMT3 proteins interact specif-
ically with histone H3 tails (Figure 5), and that the bind-
ing is disrupted by any larger modifications of K4 (di-
and trimethylation or acetylation), phosphorylation of T6
or acetylation of the H3 N-terminus (110–112,160). Inter-
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estingly, H3K4me1, which is observed at enhancers, hin-
ders the binding of the ADD domain less strongly than
di- or trimethylation (112,160), however the functional con-
sequences of this difference are unknown. The structures
of the ADD domains from DNMT3A and DNMT3L in
complex with histone H3 tail peptides were solved (110–
111,113). They showed several hydrogen bonding contacts
to both theN-terminal and lysine 4 side chain amino groups
that explain the specific recognition of the H3 peptide.
Binding to H3 tails directly activates DNMT3A by
an allosteric mechanism (122) and stimulates the methy-
lation of chromatin-bound DNA by DNMT3A in vitro
(112,113). These results indicate that the ADD domain of
DNMT3A guides DNA methylation in response to spe-
cific histone modifications and provide strong evidence that
DNA methyltransferases could be targeted to chromatin
carrying specific marks. Indeed, a strong correlation of
DNA methylation with the absence of H3K4me3 that was
observed in several genome-wide studies (90–91,161–162)
suggests that this mechanism plays an important role in
the generation of the genomic DNA methylation pattern.
This hypothesis was recently experimentally verified, as
DNMT3B artificially introduced into yeast did not methy-
late genomic regions with highH3K4me3 content (149) and
a DNMT3A enzyme with an engineered ADD domain able
to tolerate K4 methylation or T6 phosphorylation gener-
ated abnormal DNA methylation patterns in cells (160).
The mechanism of the regulation of DNMT3A activ-
ity by the ADD domain has recently been elucidated in
a seminal structural analysis by Guo et al., which showed
that unexpectedly the ADD domain could bind to the cat-
alytic domain of DNMT3A at two alternative sites, an al-
losteric site and an autoinhibitory site, in which the ADD
domain blocks the access of DNA to the DNA binding
cleft, leading to enzyme inhibition (113). Different ADD
residues contact the two regions of the catalytic domain in
the two conformations. Strikingly, critical residues contact-
ing the catalytic domain in the autoinhibitory conforma-
tion (like D529 and D531) are also involved in direct inter-
actions with the H3 peptide (113). Binding of the H3 pep-
tide to the ADD domain consequently favors the allosteric
conformation and activates DNMT3A (112–113,122). In
extrapolation, it is very likely that other DNMT3A inter-
action partners (particularly if the binding occurs via the
ADD domain) and PTMs can affect the conformation of
DNMT3A in a similarmanner and thereby directly regulate
the catalytic activity of the enzyme.Moreover, given the fact
that the DNMT3 enzymes contain additional N-terminal
domains, which would also be rearranged if the ADD do-
main changes its binding site, it is quite conceivable that the
allosteric control also affects the multimerization and even-
tually processivity of DNMT3 enzymes.
Binding of the DNMT3 PWWP domain to H3 tails methy-
lated at K36. The PWWP domain is essential for the
targeting of DNMT3A and DNMT3B to pericentromeric
chromatin (16,17) and to gene bodies via specific recogni-
tion of histone H3 tails trimethylated at lysine 36 (118).
This finding explains the genome-wide correlation of DNA
methylation andH3K36me3methylation, both in gene bod-
ies, as well as in heterochromatin. H3K36me3 accumu-
lates in euchromatin in the body of active genes and its
distribution is anti-correlated with H3K4me3 (163–167).
DNAmethylation of gene bodies mirrors that pattern, with
gene bodies of active genes showing high and those of in-
active genes low methylation (168,169). A correlation of
H3K36me3 and DNA methylation was also observed at
exon–intron boundaries, with exons showing increased lev-
els of both H3K36me3 (170) and DNA methylation (161).
In addition, a subset of heterochromatin containing repet-
itive sequences with copy number variations is strongly en-
riched in H3K36me3 (171), illustrating that direct recogni-
tion of this mark by the PWWP domain of DNMT3A con-
tributes to the heterochromatic localization of the enzyme.
The combined targeting of DNMT3A and DNMT3B by
their ADD and PWWP domains explains the strong corre-
lation of DNA methylation with the absence of H3K4me3
and presence ofH3K36me3 observed in genome-wideDNA
methylation studies (90,161).
The central role of K36 methylation in the targeting of
DNMT3 enzymes has been lately experimentally confirmed
in yeast (149). In addition, a recent study showed that the
methylation of gene bodies by DNMT3B in embryonic
cells directly depends on both the H3K36 methylation and
an intact PWWP domain (119). Interestingly, the interac-
tion of DNMT3A with H3K36me3 increases the activity
of DNMT3A on modified chromatin in in vitro (118), sug-
gesting that binding to H3 tails methylated at K36 might
have effects beyond the targeting of the DNMT3 enzymes.
However, whether there exists an allosteric mechanism con-
necting the PWWP domain with the catalytic domain, sim-
ilarly as observed for the ADD domain, remains currently
unknown.
In addition to H3 peptide binding, the PWWP domains
of DNMT3A and DNMT3B can interact with DNA, with
DNMT3B PWWP binding DNA more strongly (116,172).
Moreover, a combined interaction with methylated H3K36
and DNA has been observed for other PWWP domains as
well (118,173). This finding is not unexpected, as the K36
side chain emerges from the nucleosome body next to the
bound DNA. Simultaneous H3K36me3 and DNA bind-
ing by PWWP domains are mediated by two adjacent in-
terfaces, one featuring an aromatic cage for peptide binding
and the other one presenting a basic region for DNA in-
teraction. Recently, a mechanism for the recognition of nu-
cleosomes and subsequent DNAmethylation byDNMT3A
was proposed, based on a structural model of the full-length
DNMT3A/DNMT3L heterotetramer in complex with an
H3K36me3-modified dinucleosome (117). It suggested that
the targeting of DNMT3A occurs through a specific recog-
nition and binding of H3K36me3 and DNA by the PWWP
domain, which is followed by an activation of the catalytic
domain through the binding of H3 tails unmodified at K4
to the ADD domain, resulting in the methylation of nearby
cytosines by the catalytic domain. In addition, this model
incorporates that DNA methylation by the heterotetramer
preferentially occurs on the linker DNA between the nucle-
osomes, which is in agreement with the results of in vitro and
in vivo studies, as described above (119,146–149).
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Regulation of DNMT3 enzymes by interacting proteins
Many proteins with important roles in chromatin biol-
ogy were found to interact with DNMT3A though the
ADD domain, including protein lysine methyltransferases
SUV39H1 (174), SETDB1 (175) and E2H2 (176), deacety-
lase HDAC1, reading domain proteins, including HP1-beta
(174), Mbd3 (150) and MeCP2 (177,178) (Rajavelu et al.,
manuscript in preparation), as well as transcriptional fac-
tors PU.1 (179), Myc (180) and RP58 (181) and remodeling
factors hSNF2 (152) and SMARCA4 (150). In addition, the
ZHX1 (zinc-finger and homeobox protein 1) interacts with
the PWWP domain of DNMT3B and enhances DNMT3B-
mediated transcriptional repression (182) andHP1alpha re-
cruits DNMT3B to major satellite repeats at pericentric
heterochromatin, contributing to their methylation (183).
However, up to date, only the interaction of DNMT3 en-
zymes with DNMT3L has been studied in greater mech-
anistic details, revealing important roles for DNMT3L in
targeting, allosteric regulation and control of multimeriza-
tion of the de novoMTases. Notably, in light of the emerging
concept of DNMT3 regulation by domain rearrangements,
the numerous additional interactors could have a direct im-
pact not only on the targeting, but also on the activity of the
methyltransferases. Therefore, in order to understand the
regulation of DNMT3 enzymes in cells, further efforts de-
lineating the molecular mechanism of these interactions are
urgently needed. In particular, direct effects on the catalytic
activity via allosteric mechanisms should be investigated.
DNMT3A–DNMT3L interaction. DNMT3L co-localizes
with both DNMT3A and DNMT3B in mammalian cells
(184). It directly interacts with its C-terminal domain with
the catalytic domains of DNMT3A and DNMT3B and
stimulates the activity of both enzymes in vivo (185,186) and
in vitro (158,187–188). DNMT3L is expressed during game-
togenesis and embryonic stages, where it functions as a stim-
ulatory factor of DNTM3A and is needed for the establish-
ment of DNA methylation patterns in the developing germ
line cells (184,189–190). The structure of the complex of
the C-terminal domains of DNMT3A and DNMT3L pro-
vided the mechanistic explanation for the observed stimula-
tory effect of DNMT3L by revealing that the interaction of
both proteins through the FF interface influences the struc-
ture of DNMT3A via the -helices C, D and E. Residues
from these helices directly interact with the key catalytic and
AdoMet binding residues, which may explain the positive
effect DNMT3L exerts on DNMT3AAdoMet binding and
catalysis (123).
As described above, binding of DNMT3L to DNMT3A
leads to the disruption of DNMT3A protein oligomers. Im-
portantly, it also changes the sub-nuclear localization of
DNMT3A in cells (Figure 7). In vivo, DNMT3Lwas shown
to release DNMT3A from heterochromatin, by converting
large DNMT3A oligomers into defined tetramers, which
are homogenously distributed in the cell nucleus (157).
The redistribution of DNMT3A may be important for the
methylation of imprinted differentially methylated regions
(DMRs) and other targets in gene promoters, which gen-
erally are euchromatic. This finding goes in line with the
discovery that DNMT3L favors DNA methylation in gene
bodies (191). Hence, DNMT3L, which was originally dis-
covered as a stimulator of DNMT3A (188), also changes
the sub-nuclear localization of this enzyme (157), providing
the first example of a protein partner that influences mul-
tiple aspects of DNMT3A function. Recent data indicate
that the combined regulation of activity and localization of
DNMT3A also applies to other regulatory cues (see below
for the CK2-mediated phosphorylation of DNMT3A) and
might be a general mechanism of regulation for this family
of enzymes (Figures 3 and 5).
Interestingly, recently an investigation of the function of
catalytically inactive DNMT3B isoforms has shown that
these proteins stimulate DNA methylation by DNMT3B
(192). The observation that DNMT3L is predominantly ex-
pressed in undifferentiated cells while the DNMT3B iso-
forms are expressed in differentiated cells and also in tu-
mor cells brought the authors to the proposal that the
DNMT3B isoforms can functionally substitute DNMT3L
in these cells. The molecular mechanism of the stimulation
has not yet been clarified in detail.
Regulation of DNMT3 enzymes by nucleic acid binding
Similar as in DNMT1, additional DNA binding sites have
been identified in the N-terminal parts of the DNMT3 en-
zymes, but their exact role in DNMT3 function remains un-
known. As described above, the isolated PWWP domain of
DNMT3B features a DNA binding activity (116) and an
additional DNA binding site was detected in the PWWP
domain of DNMT3A as well (172). Equally, the very N-
terminal part of DNMT3A is able to bind DNA (120).
Moreover, it was shown that long non-coding RNAs bind
strongly to the catalytic domain ofDNMT3A, causing inhi-
bition of the enzyme (193). The authors also detected bind-
ing of RNA to allosteric sites that did not change the cat-
alytic activity. Besides, it was shown that a non-codingRNA
derived from the rDNA promoter binds to the promoter
forming RNA/DNA triplex structures that are specifically
recognized by DNMT3B, establishing a novel pathway of
RNA-directed DNA methylation (194,195). Future work
will show if RNA triplex-based recruitment emerges as new
and general principle of theRNA-dependent recruitment of
DNMTs and other chromatin interacting enzymes.
Regulation of DNMT3A by phosphorylation
The regulation of the DNMT3 enzymes by phosphoryla-
tion has not been studied almost at all, despite the fact
that more than 70 phosphorylation sites have been identi-
fied inDNMT3A andDNMT3B in global proteomics stud-
ies (http://www.phosphosite.org). So far, only one PTM of
DNMT3 enzymes has been studied in greater mechanistic
depth (196). Casein kinase 2 (CK2), a so-called survival
protein kinase that suppresses cancer cell death and is of-
ten upregulated in cancers, was shown to phosphorylate
DNMT3A at two sites; S386 and S389, which are located
next to the PWWPdomain. TheCK2-mediated phosphory-
lation increases the heterochromatic targeting ofDNMT3A
and reduces its DNA methylation activity. This effect was
reflected by changes in the cellular DNA methylation after
CK2 knockout, which may explain global hypomethylation
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Figure 7. Mechanisms regulating the activity and localization of DNMT3A. Interactors and PTMs regulate the activity and localization in a concerted
fashion.DNMT3L stimulatesDNMT3Aandpromotes its euchromatic localization. Contrarily, CK2-mediated phosphorylation downregulates the activity
of DNMT3A and promotes its heterochromatic localization, where the interaction with modified H3 tails could allosterically stimulate the enzyme.
in cancer cells overexpressing CK2. These data nicely sup-
port our model that the combined regulation of enzymatic
activity and localization is a general principle in the regu-
lation of DNMT3A (as already observed for DNMT3L in-
teraction) (Figure 7). Whether allosteric processes mediate
this regulation is not known at present.
CONCLUSIONS AND OUTLOOK
After almost 40 years of intensive research in the DNA
methylation field, we have learned a great deal about the
biochemical, structural and enzymatic properties of the
mammalian DNA methyltransferases. However, the regu-
lation of these fascinating enzymes in cells has only begun
to be uncovered. Importantly, it has been lately realized that
the precise control of DNMT activity is critically involved
in the generation and maintenance of the dynamic DNA
methylation patterns in living cells. Recent crystallographic
studies withDNMT1 andDNMT3A revealed that both en-
zymes unexpectedly undergo large domain rearrangements,
which allosterically regulate their catalytic activity. This un-
foreseen discovery has led to the important conclusion that
by influencing domain rearrangements, any PTMs or inter-
action partner (be it a protein, an allosteric DNA or a non-
coding RNA) at various parts of the methyltransferases
could directly regulate the enzymatic activity and specificity
of the DNMTs via allosteric effects, providing new and fas-
cinating perspectives on the investigation of the effects of
interactors and PTMs on these enzymes.
The combined regulation of targeting of DNMTs with
the regulation of their activity strongly increases the ef-
ficiency of DNMT control, because the enzymes can be
kept inactive until they are delivered to their target re-
gions and only become activated at these sites. The need
for a very tight control of the activity of critical enzymes
might explain, why similar allosteric regulationmechanisms
evolved for several other epigenetic enzymes as well, includ-
ing the MLL, SUV39H1 and PRC2 histone methyltrans-
ferases, which deliver the H3K4, K9 and K27 methylation
marks, respectively (197–199).
Finally, non-coding RNAs have been recognized as an
emerging player in chromatin regulation (200,201) and
RNA molecules were shown to influence DNA methyla-
tion. In plants, a process of RNA-dependent DNA methy-
lation exists, in which the RNA sequence directly guides
DNAmethylation (202). Although this pathway is absent in
mammals, binding of small and long non-coding RNAs to
mammalian DNMTs was shown to guide and regulate their
activity. In addition, the piRNA-mediated DNA methyla-
tion in the germ line of many animals, including mam-
mals (203), recapitulates many features of an RNA-directed
DNA methylation pathway, but it is not yet understood at
molecular level. The direct targeting and regulation ofDNA
methylation by genome-encoded non-coding RNAs adds
another dimension to the complex interplay between ge-
netic information (encoded in the DNA sequence) and epi-
genetic information (encoded in the chromatinmodification
pattern, including DNA methylation).
FUNDING
Work in the authors laboratory has been supported by the
DFG [JE252/10-1] and the Carl Zeiss foundation. Funding
for open access charge were provided by Stuttgart Univer-
sity.
Conflict of interest statement.None declared.
REFERENCES
1. Jeltsch,A. and Jurkowska,R.Z. (2014) New concepts in DNA
methylation. Trends Biochem. Sci., 39, 310–318.
2. Jones,P.A. (2012) Functions of DNA methylation: islands, start
sites, gene bodies and beyond. Nat. Rev. Genet., 13, 484–492.
3. Jurkowska,R.Z., Jurkowski,T.P. and Jeltsch,A. (2011) Structure and
function of mammalian DNA methyltransferases. Chembiochem,
12, 206–222.
4. Klose,R.J. and Bird,A.P. (2006) Genomic DNA methylation: the
mark and its mediators. Trends Biochem. Sci., 31, 89–97.
5. Suzuki,M.M. and Bird,A. (2008) DNA methylation landscapes:
provocative insights from epigenomics.Nat. Rev. Genet., 9, 465–476.
6. Baylin,S.B. and Jones,P.A. (2011) A decade of exploring the cancer
epigenome - biological and translational implications. Nat. Rev.
Cancer, 11, 726–734.
D
ow
nloaded from
 https://academ
ic.oup.com
/nar/article-abstract/44/18/8556/2468361 by Acquisitions user on 13 D
ecem
ber 2018
Nucleic Acids Research, 2016, Vol. 44, No. 18 8571
7. Bergman,Y. and Cedar,H. (2013) DNA methylation dynamics in
health and disease. Nat. Struct. Mol. Biol., 20, 274–281.
8. Suva,M.L., Riggi,N. and Bernstein,B.E. (2013) Epigenetic
reprogramming in cancer. Science, 339, 1567–1570.
9. Hamidi,T., Singh,A.K. and Chen,T. (2015) Genetic alterations of
DNA methylation machinery in human diseases. Epigenomics, 7,
247–265.
10. Wu,T.P., Wang,T., Seetin,M.G., Lai,Y., Zhu,S., Lin,K., Liu,Y.,
Byrum,S.D., Mackintosh,S.G., Zhong,M. et al. (2016) DNA
methylation on N(6)-adenine in mammalian embryonic stem cells.
Nature, 532, 329–333.
11. Luo,G.Z., Blanco,M.A., Greer,E.L., He,C. and Shi,Y. (2015) DNA
N(6)-methyladenine: A new epigenetic mark in eukaryotes? Nat.
Rev. Mol. Cell Biol., 16, 705–710.
12. Zhang,G., Huang,H., Liu,D., Cheng,Y., Liu,X., Zhang,W., Yin,R.,
Zhang,D., Zhang,P., Liu,J. et al. (2015) N6-methyladenine DNA
modification in Drosophila. Cell, 161, 893–906.
13. Greer,E.L., Blanco,M.A., Gu,L., Sendinc,E., Liu,J.,
Aristizabal-Corrales,D., Hsu,C.H., Aravind,L., He,C. and Shi,Y.
(2015) DNAMethylation on N6-Adenine in C. elegans. Cell, 161,
868–878.
14. Okano,M., Xie,S.P. and Li,E. (1998) Cloning and characterization
of a family of novel mammalian DNA (cytosine-5)
methyltransferases. Nat. Genet., 19, 219–220.
15. Gowher,H. and Jeltsch,A. (2001) Enzymatic properties of
recombinant Dnmt3a DNA methyltransferase from mouse: The
enzyme modifies DNA in a non-processive manner and also
methylates non-CpA sites. J. Mol. Biol., 309, 1201–1208.
16. Chen,T.P., Tsujimoto,N. and Li,E. (2004) The PWWP domain of
Dnmt3a and Dnmt3b is required for directing DNA methylation to
the major satellite repeats at pericentric heterochromatin.Mol. Cell.
Biol., 24, 9048–9058.
17. Ge,Y.Z., Pu,M.T., Gowher,H., Wu,H.P., Ding,J.P., Jeltsch,A. and
Xu,G.L. (2004) Chromatin targeting of de novo DNA
methyltransferases by the PWWP domain. J. Biol. Chem., 279,
25447–25454.
18. Jeong,S., Liang,G.N., Sharma,S., Lin,J.C., Choi,S.H., Han,H.,
Yoo,C.B., Egger,G., Yang,A.S. and Jones,P.A. (2009) Selective
Anchoring of DNAMethyltransferases 3A and 3B to Nucleosomes
Containing Methylated DNA.Mol. Cell. Biol., 29, 5366–5376.
19. Sharma,S., De Carvalho,D.D., Jeong,S., Jones,P.A. and Liang,G.
(2011) Nucleosomes containing methylated DNA stabilize DNA
methyltransferases 3A/3B and ensure faithful epigenetic
inheritance. PLoS Genet., 7, e1001286.
20. Jeltsch,A. (2002) Beyond Watson and Crick: DNA methylation and
molecular enzymology of DNA methyltransferases. Chembiochem,
3, 275–293.
21. Hermann,A., Gowher,H. and Jeltsch,A. (2004) Biochemistry and
biology of mammalian DNA methyltransferases. Cell. Mol. Life
Sci., 61, 2571–2587.
22. Cheng,X. and Blumenthal,R.M. (2008) Mammalian DNA
methyltransferases: A structural perspective. Structure, 16, 341–350.
23. Robertson,K.D., Uzvolgyi,E., Liang,G., Talmadge,C., Sumegi,J.,
Gonzales,F.A. and Jones,P.A. (1999) The human DNA
methyltransferases (DNMTs) 1, 3a and 3b: coordinate mRNA
expression in normal tissues and overexpression in tumors. Nucleic
Acids Res., 27, 2291–2298.
24. Easwaran,H.P., Schermelleh,L., Leonhardt,H. and Cardoso,M.C.
(2004) Replication-independent chromatin loading of Dnmt1
during G2 and M phases. EMBO Rep., 5, 1181–1186.
25. Leonhardt,H., Page,A.W., Weier,H.U. and Bestor,T.H. (1992) A
targeting sequence directs DNA methyltransferase to sites of DNA
replication in mammalian nuclei. Cell, 71, 865–873.
26. Riggs,A.D. and Xiong,Z. (2004) Methylation and epigenetic
fidelity. Proc. Natl. Acad. Sci. U.S.A., 101, 4–5.
27. Jones,P.A. and Liang,G. (2009) Rethinking how DNA methylation
patterns are maintained. Nat. Rev. Genet., 10, 805–811.
28. Cheng,X. and Roberts,R.J. (2001) AdoMet-dependent methylation,
DNA methyltransferases and base flipping. Nucleic Acids Res., 29,
3784–3795.
29. Song,J., Teplova,M., Ishibe-Murakami,S. and Patel,D.J. (2012)
Structure-based mechanistic insights into DNMT1-mediated
maintenance DNA methylation. Science, 335, 709–712.
30. Du,Q., Wang,Z. and Schramm,V.L. (2016) Human DNMT1
transition state structure.Proc. Natl. Acad. Sci. U.S.A., 113,
2916–2921.
31. Reither,S., Li,F., Gowher,H. and Jeltsch,A. (2003) Catalytic
mechanism of DNA-(cytosine-C5)-methyltransferases revisited:
covalent intermediate formation is not essential for methyl group
transfer by the murine Dnmt3a enzyme. J. Mol. Biol., 329, 675–684.
32. Gowher,H., Loutchanwoot,P., Vorobjeva,O., Handa,V.,
Jurkowska,R.Z., Jurkowski,T.P. and Jeltsch,A. (2006) Mutational
analysis of the catalytic domain of the murine Dnmt3a
DNA-(cytosine C5)-methyltransferase. J. Mol. Biol., 357, 928–941.
33. Lukashevich,O.V., Cherepanova,N.A., Jurkovska,R.Z., Jeltsch,A.
and Gromova,E.S. (2016) Conserved motif VIII of murine DNA
methyltransferase Dnmt3a is essential for methylation activity.
BMC Biochem., 17, 7.
34. Rountree,M.R., Bachman,K.E. and Baylin,S.B. (2000) DNMT1
binds HDAC2 and a new co-repressor, DMAP1, to form a complex
at replication foci. Nat. Genet., 25, 269–277.
35. Mohan,K.N., Ding,F. and Chaillet,J.R. (2011) Distinct roles of
DMAP1 in mouse development.Mol. Cell. Biol., 31, 1861–1869.
36. Ding,F. and Chaillet,J.R. (2002) In vivo stabilization of the Dnmt1
(cytosine-5)- methyltransferase protein. Proc. Natl. Acad. Sci.
U.S.A., 99, 14861–14866.
37. Chuang,L.S., Ian,H.I., Koh,T.W., Ng,H.H., Xu,G. and Li,B.F.
(1997) Human DNA-(cytosine-5) methyltransferase-PCNA
complex as a target for p21WAF1. Science, 277, 1996–2000.
38. Egger,G., Jeong,S., Escobar,S.G., Cortez,C.C., Li,T.W., Saito,Y.,
Yoo,C.B., Jones,P.A. and Liang,G. (2006) Identification of DNMT1
(DNA methyltransferase 1) hypomorphs in somatic knockouts
suggests an essential role for DNMT1 in cell survival. Proc. Natl.
Acad. Sci. U.S.A., 103, 14080–14085.
39. Suetake,I., Hayata,D. and Tajima,S. (2006) The amino-terminus of
mouse DNA methyltransferase 1 forms an independent domain and
binds to DNA with the sequence involving PCNA binding motif. J.
Biochem., 140, 763–776.
40. Berkyurek,A.C., Suetake,I., Arita,K., Takeshita,K., Nakagawa,A.,
Shirakawa,M. and Tajima,S. (2014) The DNA methyltransferase
Dnmt1 directly interacts with the SET and RING finger-associated
(SRA) domain of the multifunctional protein Uhrf1 to facilitate
accession of the catalytic center to hemi-methylated DNA. J. Biol.
Chem., 289, 379–386.
41. Bashtrykov,P., Jankevicius,G., Jurkowska,R.Z., Ragozin,S. and
Jeltsch,A. (2014) The UHRF1 protein stimulates the activity and
specificity of the maintenance DNA methyltransferase DNMT1 by
an allosteric mechanism. J. Biol. Chem., 289, 4106–4115.
42. Pradhan,M., Esteve,P.O., Chin,H.G., Samaranayke,M., Kim,G.D.
and Pradhan,S. (2008) CXXC domain of human DNMT1 is
essential for enzymatic activity. Biochemistry, 47, 10000–10009.
43. Song,J., Rechkoblit,O., Bestor,T.H. and Patel,D.J. (2011) Structure
of DNMT1-DNA complex reveals a role for autoinhibition in
maintenance DNA methylation. Science, 331, 1036–1040.
44. Bashtrykov,P., Jankevicius,G., Smarandache,A., Jurkowska,R.Z.,
Ragozin,S. and Jeltsch,A. (2012) Specificity of Dnmt1 for
methylation of hemimethylated CpG sites resides in its catalytic
domain. Chem. Biol., 19, 572–578.
45. Du,J., Zhong,X., Bernatavichute,Y.V., Stroud,H., Feng,S., Caro,E.,
Vashisht,A.A., Terragni,J., Chin,H.G., Tu,A. et al. (2012) Dual
binding of chromomethylase domains to H3K9me2-containing
nucleosomes directs DNA methylation in plants. Cell, 151, 167–180.
46. Takeshita,K., Suetake,I., Yamashita,E., Suga,M., Narita,H.,
Nakagawa,A. and Tajima,S. (2011) Structural insight into
maintenance methylation by mouse DNA methyltransferase 1
(Dnmt1). Proc. Natl. Acad. Sci. U.S.A., 108, 9055–9059.
47. Syeda,F., Fagan,R.L., Wean,M., Avvakumov,G.V., Walker,J.R.,
Xue,S., Dhe-Paganon,S. and Brenner,C. (2011) The replication
focus targeting sequence (RFTS) domain is a DNA-competitive
inhibitor of Dnmt1. J. Biol. Chem., 286, 15344–15351.
48. Zhang,Z.M., Liu,S., Lin,K., Luo,Y., Perry,J.J., Wang,Y. and Song,J.
(2015) Crystal Structure of Human DNAMethyltransferase 1. J.
Mol. Biol., 427, 2520–2531.
49. Bashtrykov,P., Ragozin,S. and Jeltsch,A. (2012) Mechanistic details
of the DNA recognition by the Dnmt1 DNA methyltransferase.
FEBS Lett., 586, 1821–1823.
D
ow
nloaded from
 https://academ
ic.oup.com
/nar/article-abstract/44/18/8556/2468361 by Acquisitions user on 13 D
ecem
ber 2018
8572 Nucleic Acids Research, 2016, Vol. 44, No. 18
50. Fatemi,M., Hermann,A., Pradhan,S. and Jeltsch,A. (2001) The
activity of the murine DNA methyltransferase Dnmt1 is controlled
by interaction of the catalytic domain with the N-terminal part of
the enzyme leading to an allosteric activation of the enzyme after
binding to methylated DNA. J. Mol. Biol., 309, 1189–1199.
51. Margot,J.B., Ehrenhofer-Murray,A.E. and Leonhardt,H. (2003)
Interactions within the mammalian DNA methyltransferase family.
BMCMol. Biol., 4, 7.
52. Goyal,R., Reinhardt,R. and Jeltsch,A. (2006) Accuracy of DNA
methylation pattern preservation by the Dnmt1 methyltransferase.
Nucleic Acids Res., 34, 1182–1188.
53. Jeltsch,A. (2006) On the enzymatic properties of Dnmt1: specificity,
processivity, mechanism of linear diffusion and allosteric regulation
of the enzyme. Epigenetics, 1, 63–66.
54. Bashtrykov,P., Rajavelu,A., Hackner,B., Ragozin,S., Carell,T. and
Jeltsch,A. (2014) Targeted mutagenesis results in an activation of
DNA methyltransferase 1 and confirms an autoinhibitory role of its
RFTS domain. Chembiochem, 15, 743–748.
55. Hermann,A., Goyal,R. and Jeltsch,A. (2004) The Dnmt1
DNA-(cytosine-C5)-methyltransferase methylates DNA
processively with high preference for hemimethylated target sites. J.
Biol. Chem., 279, 48350–48359.
56. Vilkaitis,G., Suetake,I., Klimasauskas,S. and Tajima,S. (2005)
Processive methylation of hemimethylated CpG sites by mouse
Dnmt1 DNA methyltransferase. J. Biol. Chem., 280, 64–72.
57. Liu,Y., Oakeley,E.J., Sun,L. and Jost,J.P. (1998) Multiple domains
are involved in the targeting of the mouse DNA methyltransferase
to the DNA replication foci. Nucleic Acids Res., 26, 1038–1045.
58. Iida,T., Suetake,I., Tajima,S., Morioka,H., Ohta,S., Obuse,C. and
Tsurimoto,T. (2002) PCNA clamp facilitates action of DNA
cytosine methyltransferase 1 on hemimethylated DNA. Genes Cells,
7, 997–1007.
59. O’Keefe,R.T., Henderson,S.C. and Spector,D.L. (1992) Dynamic
organization of DNA replication in mammalian cell nuclei:
Spatially and temporally defined replication of chromosome-specific
alpha-satellite DNA sequences. J. Cell Biol., 116, 1095–1110.
60. Bostick,M., Kim,J.K., Esteve,P.O., Clark,A., Pradhan,S. and
Jacobsen,S.E. (2007) UHRF1 plays a role in maintaining DNA
methylation in mammalian cells. Science, 317, 1760–1764.
61. Sharif,J., Muto,M., Takebayashi,S., Suetake,I., Iwamatsu,A.,
Endo,T.A., Shinga,J., Mizutani-Koseki,Y., Toyoda,T., Okamura,K.
et al. (2007) The SRA protein Np95 mediates epigenetic inheritance
by recruiting Dnmt1 to methylated DNA. Nature, 450, 908–912.
62. Avvakumov,G.V., Walker,J.R., Xue,S., Li,Y., Duan,S., Bronner,C.,
Arrowsmith,C.H. and Dhe-Paganon,S. (2008) Structural basis for
recognition of hemi-methylated DNA by the SRA domain of
human UHRF1. Nature, 455, 822–825.
63. Hashimoto,H., Horton,J.R., Zhang,X., Bostick,M., Jacobsen,S.E.
and Cheng,X. (2008) The SRA domain of UHRF1 flips
5-methylcytosine out of the DNA helix. Nature, 455, 826–829.
64. Arita,K., Ariyoshi,M., Tochio,H., Nakamura,Y. and Shirakawa,M.
(2008) Recognition of hemi-methylated DNA by the SRA protein
UHRF1 by a base-flipping mechanism. Nature, 455, 818–821.
65. Jeltsch,A. (2008) Reading and writing DNA methylation. Nat.
Struct. Mol. Biol., 15, 1003–1004.
66. Nady,N., Lemak,A., Walker,J.R., Avvakumov,G.V., Kareta,M.S.,
Achour,M., Xue,S., Duan,S., Allali-Hassani,A., Zuo,X. et al.
(2011) Recognition of multivalent histone states associated with
heterochromatin by UHRF1 protein. J. Biol. Chem., 286,
24300–24311.
67. Rothbart,S.B., Krajewski,K., Nady,N., Tempel,W., Xue,S.,
Badeaux,A.I., Barsyte-Lovejoy,D., Martinez,J.Y., Bedford,M.T.,
Fuchs,S.M. et al. (2012) Association of UHRF1 with methylated
H3K9 directs the maintenance of DNA methylation. Nat. Struct.
Mol. Biol., 19, 1155–1160.
68. Hu,L., Li,Z., Wang,P., Lin,Y. and Xu,Y. (2011) Crystal structure of
PHD domain of UHRF1 and insights into recognition of
unmodified histone H3 arginine residue 2. Cell Res., 21, 1374–1378.
69. Rajakumara,E., Wang,Z., Ma,H., Hu,L., Chen,H., Lin,Y., Guo,R.,
Wu,F., Li,H., Lan,F. et al. (2011) PHD finger recognition of
unmodified histone H3R2 links UHRF1 to regulation of
euchromatic gene expression.Mol. Cell, 43, 275–284.
70. Wang,C., Shen,J., Yang,Z., Chen,P., Zhao,B., Hu,W., Lan,W.,
Tong,X., Wu,H., Li,G. et al. (2011) Structural basis for site-specific
reading of unmodified R2 of histone H3 tail by UHRF1 PHD
finger. Cell Res., 21, 1379–1382.
71. Qin,W., Wolf,P., Liu,N., Link,S., Smets,M., La Mastra,F., Forne,I.,
Pichler,G., Horl,D., Fellinger,K. et al. (2015) DNA methylation
requires a DNMT1 ubiquitin interacting motif (UIM) and histone
ubiquitination. Cell Res., 25, 911–929.
72. Rothbart,S.B., Dickson,B.M., Ong,M.S., Krajewski,K.,
Houliston,S., Kireev,D.B., Arrowsmith,C.H. and Strahl,B.D. (2013)
Multivalent histone engagement by the linked tandem Tudor and
PHD domains of UHRF1 is required for the epigenetic inheritance
of DNA methylation. Genes Dev., 27, 1288–1298.
73. Liu,X., Gao,Q., Li,P., Zhao,Q., Zhang,J., Li,J., Koseki,H. and
Wong,J. (2013) UHRF1 targets DNMT1 for DNA methylation
through cooperative binding of hemi-methylated DNA and
methylated H3K9. Nat. Commun., 4, 1563.
74. von Meyenn,F., Iurlaro,M., Habibi,E., Liu,N.Q.,
Salehzadeh-Yazdi,A., Santos,F., Petrini,E., Milagre,I., Yu,M.,
Xie,Z. et al. (2016) Impairment of DNA methylation maintenance
is the main cause of global demethylation in naive embryonic stem
cells.Mol. Cell, 62, 983.
75. Nishiyama,A., Yamaguchi,L., Sharif,J., Johmura,Y., Kawamura,T.,
Nakanishi,K., Shimamura,S., Arita,K., Kodama,T., Ishikawa,F.
et al. (2013) Uhrf1-dependent H3K23 ubiquitylation couples
maintenance DNA methylation and replication. Nature, 502,
249–253.
76. Fang,J., Cheng,J.D., Wang,J.L., Zhang,Q., Liu,M.J., Gong,R.,
Wang,P., Zhang,X.D., Feng,Y.Y., Lan,W.X. et al. (2016)
Hemi-methylated DNA opens a closed conformation of UHRF1 to
facilitate its histone recognition. Nat. Commun., 7, 11197.
77. Du,Z., Song,J., Wang,Y., Zhao,Y., Guda,K., Yang,S., Kao,H.Y.,
Xu,Y., Willis,J., Markowitz,S.D. et al. (2010) DNMT1 stability is
regulated by proteins coordinating deubiquitination and
acetylation-driven ubiquitination. Sci. Signal., 3, ra80.
78. Felle,M., Joppien,S., Nemeth,A., Diermeier,S., Thalhammer,V.,
Dobner,T., Kremmer,E., Kappler,R. and Langst,G. (2011) The
USP7/Dnmt1 complex stimulates the DNA methylation activity of
Dnmt1 and regulates the stability of UHRF1. Nucleic Acids Res.,
39, 8355–8365.
79. Qin,W., Leonhardt,H. and Spada,F. (2011) Usp7 and Uhrf1 control
ubiquitination and stability of the maintenance DNA
methyltransferase Dnmt1. J. Cell. Biochem., 112, 439–444.
80. Cheng,J., Yang,H., Fang,J., Ma,L., Gong,R., Wang,P., Li,Z. and
Xu,Y. (2015) Molecular mechanism for USP7-mediated DNMT1
stabilization by acetylation. Nat. Commun., 6, 7023.
81. Nicholson,B. and Suresh Kumar,K.G. (2011) The multifaceted
roles of USP7: new therapeutic opportunities. Cell Biochem.
Biophys., 60, 61–68.
82. Fatemi,M., Hermann,A., Gowher,H. and Jeltsch,A. (2002) Dnmt3a
and Dnmt1 functionally cooperate during de novo methylation of
DNA. Eur. J. Biochem., 269, 4981–4984.
83. Christman,J.K., Sheikhnejad,G., Marasco,C.J. and Sufrin,J.R.
(1995) 5-Methyl-2′-deoxycytidine in single-stranded DNA can act
in cis to signal de novo DNA methylation. Proc. Natl. Acad. Sc.
U.S.A., 92, 7347–7351.
84. Bacolla,A., Pradhan,S., Roberts,R.J. and Wells,R.D. (1999)
Recombinant human DNA (cytosine-5) methyltransferase. II.
Steady-state kinetics reveal allosteric activation by methylated dna.
J. Biol. Chem., 274, 33011–33019.
85. Pradhan,S. and Esteve,P.O. (2003) Allosteric activator domain of
maintenance human DNA (cytosine-5) methyltransferase and its
role in methylation spreading. Biochemistry, 42, 5321–5332.
86. Svedruzic,Z.M. and Reich,N.O. (2005) DNA cytosine C5
methyltransferase Dnmt1: Catalysis-dependent release of allosteric
inhibition. Biochemistry, 44, 9472–9485.
87. Flynn,J., Fang,J.Y., Mikovits,J.A. and Reich,N.O. (2003) A potent
cell-active allosteric inhibitor of murine DNA cytosine C5
methyltransferase. J. Biol. Chem., 278, 8238–8243.
88. Bacolla,A., Pradhan,S., Larson,J.E., Roberts,R.J. and Wells,R.D.
(2001) Recombinant human DNA (cytosine-5) methyltransferase.
III. Allosteric control, reaction order, and influence of plasmid
topology and triplet repeat length on methylation of the fragile X
CGG.CCG sequence. J. Biol. Chem., 276, 18605–18613.
89. Eckhardt,F., Lewin,J., Cortese,R., Rakyan,V.K., Attwood,J.,
Burger,M., Burton,J., Cox,T.V., Davies,R., Down,T.A. et al. (2006)
D
ow
nloaded from
 https://academ
ic.oup.com
/nar/article-abstract/44/18/8556/2468361 by Acquisitions user on 13 D
ecem
ber 2018
Nucleic Acids Research, 2016, Vol. 44, No. 18 8573
DNA methylation profiling of human chromosomes 6, 20 and 22.
Nat. Genet., 38, 1378–1385.
90. Meissner,A., Mikkelsen,T.S., Gu,H., Wernig,M., Hanna,J.,
Sivachenko,A., Zhang,X., Bernstein,B.E., Nusbaum,C., Jaffe,D.B.
et al. (2008) Genome-scale DNA methylation maps of pluripotent
and differentiated cells. Nature, 454, 766–770.
91. Zhang,Y., Rohde,C., Tierling,S., Jurkowski,T.P., Bock,C.,
Santacruz,D., Ragozin,S., Reinhardt,R., Groth,M., Walter,J. et al.
(2009) DNA methylation analysis of chromosome 21 gene
promoters at single base pair and single allele resolution. PLoS
Genet., 5, e1000438.
92. Glickman,J.F., Flynn,J. and Reich,N.O. (1997) Purification and
characterization of recombinant baculovirus-expressed mouse
DNA methyltransferase. Biochem. Biophys. Res. Commun., 230,
280–284.
93. Di Ruscio,A., Ebralidze,A.K., Benoukraf,T., Amabile,G.,
Goff,L.A., Terragni,J., Figueroa,M.E., De Figueiredo Pontes,L.L.,
Alberich-Jorda,M., Zhang,P. et al. (2013) DNMT1-interacting
RNAs block gene-specific DNA methylation. Nature, 503, 371–376.
94. Zhang,G., Esteve,P.O., Chin,H.G., Terragni,J., Dai,N., Correa,I.R.
Jr and Pradhan,S. (2015) Small RNA-mediated DNA (cytosine-5)
methyltransferase 1 inhibition leads to aberrant DNA methylation.
Nucleic Acids Res., 43, 6112–6124.
95. Glickman,J.F., Pavlovich,J.G. and Reich,N.O. (1997) Peptide
mapping of the murine DNA methyltransferase reveals a major
phosphorylation site and the start of translation. J. Biol. Chem.,
272, 17851–17857.
96. Goyal,R., Rathert,P., Laser,H., Gowher,H. and Jeltsch,A. (2007)
Phosphorylation of serine-515 activates the Mammalian
maintenance methyltransferase Dnmt1. Epigenetics, 2, 155–160.
97. Sugiyama,Y., Hatano,N., Sueyoshi,N., Suetake,I., Tajima,S.,
Kinoshita,E., Kinoshita-Kikuta,E., Koike,T. and Kameshita,I.
(2010) The DNA-binding activity of mouse DNA methyltransferase
1 is regulated by phosphorylation with casein kinase 1delta/epsilon.
Biochem. J., 427, 489–497.
98. Hervouet,E., Lalier,L., Debien,E., Cheray,M., Geairon,A.,
Rogniaux,H., Loussouarn,D., Martin,S.A., Vallette,F.M. and
Cartron,P.F. (2010) Disruption of Dnmt1/PCNA/UHRF1
interactions promotes tumorigenesis from human and mice glial
cells. PLoS One, 5, e11333.
99. Esteve,P.O., Chang,Y., Samaranayake,M., Upadhyay,A.K.,
Horton,J.R., Feehery,G.R., Cheng,X. and Pradhan,S. (2011) A
methylation and phosphorylation switch between an adjacent lysine
and serine determines human DNMT1 stability. Nat. Struct. Mol.
Biol., 18, 42–48.
100. Esteve,P.O., Zhang,G., Ponnaluri,V.K., Deepti,K., Chin,H.G.,
Dai,N., Sagum,C., Black,K., Correa,I.R. Jr, Bedford,M.T. et al.
(2016) Binding of 14-3-3 reader proteins to phosphorylated
DNMT1 facilitates aberrant DNA methylation and gene
expression. Nucleic Acids Res., 44, 1642–1656.
101. Lavoie,G., Esteve,P.O., Laulan,N.B., Pradhan,S. and St-Pierre,Y.
(2011) PKC isoforms interact with and phosphorylate DNMT1.
BMC Biol., 9, 31.
102. Kim,S.C., Sprung,R., Chen,Y., Xu,Y., Ball,H., Pei,J., Cheng,T.,
Kho,Y., Xiao,H., Xiao,L. et al. (2006) Substrate and functional
diversity of lysine acetylation revealed by a proteomics survey.Mol.
Cell, 23, 607–618.
103. Choudhary,C., Kumar,C., Gnad,F., Nielsen,M.L., Rehman,M.,
Walther,T.C., Olsen,J.V. and Mann,M. (2009) Lysine acetylation
targets protein complexes and co-regulates major cellular functions.
Science, 325, 834–840.
104. Peng,L., Yuan,Z., Ling,H., Fukasawa,K., Robertson,K.,
Olashaw,N., Koomen,J., Chen,J., Lane,W.S. and Seto,E. (2011)
SIRT1 deacetylates the DNA methyltransferase 1 (DNMT1)
protein and alters its activities.Mol. Cell. Biol., 31, 4720–4734.
105. Zhou,Q., Agoston,A.T., Atadja,P., Nelson,W.G. and Davidson,N.E.
(2008) Inhibition of histone deacetylases promotes
ubiquitin-dependent proteasomal degradation of DNA
methyltransferase 1 in human breast cancer cells.Mol. Cancer Res.,
6, 873–883.
106. Esteve,P.O., Chin,H.G., Benner,J., Feehery,G.R.,
Samaranayake,M., Horwitz,G.A., Jacobsen,S.E. and Pradhan,S.
(2009) Regulation of DNMT1 stability through SET7-mediated
lysine methylation in mammalian cells. Proc. Natl. Acad. Sci.
U.S.A., 106, 5076–5081.
107. Wang,J., Hevi,S., Kurash,J.K., Lei,H., Gay,F., Bajko,J., Su,H.,
Sun,W., Chang,H., Xu,G. et al. (2009) The lysine demethylase
LSD1 (KDM1) is required for maintenance of global DNA
methylation. Nat. Genet., 41, 125–129.
108. Argentaro,A., Yang,J.C., Chapman,L., Kowalczyk,M.S.,
Gibbons,R.J., Higgs,D.R., Neuhaus,D. and Rhodes,D. (2007)
Structural consequences of disease-causing mutations in the
ATRX-DNMT3-DNMT3L (ADD) domain of the
chromatin-associated protein ATRX. Proc. Natl. Acad. Sci. U.S.A,
104, 11939–11944.
109. Hashimoto,H., Vertino,P.M. and Cheng,X. (2010) Molecular
coupling of DNA methylation and histone methylation.
Epigenomics, 2, 657–669.
110. Ooi,S.K., Qiu,C., Bernstein,E., Li,K., Jia,D., Yang,Z.,
Erdjument-Bromage,H., Tempst,P., Lin,S.P., Allis,C.D. et al. (2007)
DNMT3L connects unmethylated lysine 4 of histone H3 to de novo
methylation of DNA. Nature, 448, 714–717.
111. Otani,J., Nankumo,T., Arita,K., Inamoto,S., Ariyoshi,M. and
Shirakawa,M. (2009) Structural basis for recognition of H3K4
methylation status by the DNA methyltransferase 3A
ATRX-DNMT3-DNMT3L domain. EMBO Rep., 10, 1235–1241.
112. Zhang,Y., Jurkowska,R., Soeroes,S., Rajavelu,A., Dhayalan,A.,
Bock,I., Rathert,P., Brandt,O., Reinhardt,R., Fischle,W. et al.
(2010) Chromatin methylation activity of Dnmt3a and Dnmt3a/3L
is guided by interaction of the ADD domain with the histone H3
tail. Nucleic Acids Res., 38, 4246–4253.
113. Guo,X., Wang,L., Li,J., Ding,Z., Xiao,J., Yin,X., He,S., Shi,P.,
Dong,L., Li,G. et al. (2015) Structural insight into autoinhibition
and histone H3-induced activation of DNMT3A. Nature, 517,
640–644.
114. Dhayalan,A., Tamas,R., Bock,I., Tattermusch,A., Dimitrova,E.,
Kudithipudi,S., Ragozin,S. and Jeltsch,A. (2011) The ATRX-ADD
domain binds to H3 tail peptides and reads the combined
methylation state of K4 and K9. Hum. Mol. Genet., 20, 2195–2203.
115. Qin,S. and Min,J. (2014) Structure and function of the
nucleosome-binding PWWP domain. Trends Biochem. Sci., 39,
536–547.
116. Qiu,C., Sawada,K., Zhang,X. and Cheng,X. (2002) The PWWP
domain of mammalian DNA methyltransferase Dnmt3b defines a
new family of DNA-binding folds. Nat. Struct. Biol., 9, 217–224.
117. Rondelet,G., Dal Maso,T., Willems,L. and Wouters,J. (2016)
Structural basis for recognition of histone H3K36me3 nucleosome
by human de novo DNA methyltransferases 3A and 3B. J. Struct.
Biol., 194, 357–367.
118. Dhayalan,A., Rajavelu,A., Rathert,P., Tamas,R., Jurkowska,R.Z.,
Ragozin,S. and Jeltsch,A. (2010) The Dnmt3a PWWP domain
reads histone 3 lysine 36 trimethylation and guides DNA
methylation. J. Biol. Chem., 285, 26114–26120.
119. Baubec,T., Colombo,D.F., Wirbelauer,C., Schmidt,J., Burger,L.,
Krebs,A.R., Akalin,A. and Schubeler,D. (2015) Genomic profiling
of DNA methyltransferases reveals a role for DNMT3B in genic
methylation. Nature, 520, 243–247.
120. Suetake,I., Mishima,Y., Kimura,H., Lee,Y.H., Goto,Y.,
Takeshima,H., Ikegami,T. and Tajima,S. (2011) Characterization of
DNA-binding activity in the N-terminal domain of the DNA
methyltransferase Dnmt3a. Biochem. J., 437, 141–148.
121. Gowher,H. and Jeltsch,A. (2002) Molecular enzymology of the
catalytic domains of the Dnmt3a and Dnmt3b DNA
methyltransferases. J. Biol. Chem., 277, 20409–20414.
122. Li,B.Z., Huang,Z., Cui,Q.Y., Song,X.H., Du,L., Jeltsch,A.,
Chen,P., Li,G., Li,E. and Xu,G.L. (2011) Histone tails regulate
DNA methylation by allosterically activating de novo
methyltransferase. Cell Res., 21, 1172–1181.
123. Jia,D., Jurkowska,R.Z., Zhang,X., Jeltsch,A. and Cheng,X. (2007)
Structure of Dnmt3a bound to Dnmt3L suggests a model for de
novo DNA methylation. Nature, 449, 248–251.
124. Jurkowska,R.Z., Anspach,N., Urbanke,C., Jia,D., Reinhardt,R.,
Nellen,W., Cheng,X. and Jeltsch,A. (2008) Formation of
nucleoprotein filaments by mammalian DNA methyltransferase
Dnmt3a in complex with regulator Dnmt3L. Nucleic Acids Res., 36,
6656–6663.
D
ow
nloaded from
 https://academ
ic.oup.com
/nar/article-abstract/44/18/8556/2468361 by Acquisitions user on 13 D
ecem
ber 2018
8574 Nucleic Acids Research, 2016, Vol. 44, No. 18
125. Cokus,S.J., Feng,S., Zhang,X., Chen,Z., Merriman,B.,
Haudenschild,C.D., Pradhan,S., Nelson,S.F., Pellegrini,M. and
Jacobsen,S.E. (2008) Shotgun bisulphite sequencing of the
Arabidopsis genome reveals DNA methylation patterning. Nature,
452, 215–219.
126. Lister,R., Pelizzola,M., Dowen,R.H., Hawkins,R.D., Hon,G.,
Tonti-Filippini,J., Nery,J.R., Lee,L., Ye,Z., Ngo,Q.M. et al. (2009)
Human DNA methylomes at base resolution show widespread
epigenomic differences. Nature, 462, 315–322.
127. Chodavarapu,R.K., Feng,S., Bernatavichute,Y.V., Chen,P.Y.,
Stroud,H., Yu,Y., Hetzel,J.A., Kuo,F., Kim,J., Cokus,S.J. et al.
(2010) Relationship between nucleosome positioning and DNA
methylation. Nature, 466, 388–392.
128. Smallwood,S.A., Tomizawa,S., Krueger,F., Ruf,N., Carli,N.,
Segonds-Pichon,A., Sato,S., Hata,K., Andrews,S.R. and Kelsey,G.
(2011) Dynamic CpG island methylation landscape in oocytes and
preimplantation embryos. Nat. Genet., 43, 811–814.
129. Aoki,A., Suetake,I., Miyagawa,J., Fujio,T., Chijiwa,T., Sasaki,H.
and Tajima,S. (2001) Enzymatic properties of de novo-type mouse
DNA (cytosine-5) methyltransferases. Nucleic Acids Res., 29,
3506–3512.
130. Ramsahoye,B.H., Biniszkiewicz,D., Lyko,F., Clark,V., Bird,A.P.
and Jaenisch,R. (2000) Non-CpG methylation is prevalent in
embryonic stem cells and may be mediated by DNA
methyltransferase 3a. Proc. Natl. Acad. Sci. U.S.A., 97, 5237–5242.
131. Varley,K.E., Gertz,J., Bowling,K.M., Parker,S.L., Reddy,T.E.,
Pauli-Behn,F., Cross,M.K., Williams,B.A.,
Stamatoyannopoulos,J.A., Crawford,G.E. et al. (2013) Dynamic
DNA methylation across diverse human cell lines and tissues.
Genome Res., 23, 555–567.
132. Lister,R., Mukamel,E.A., Nery,J.R., Urich,M., Puddifoot,C.A.,
Johnson,N.D., Lucero,J., Huang,Y., Dwork,A.J., Schultz,M.D.
et al. (2013) Global epigenomic reconfiguration during mammalian
brain development. Science, 341, 1237905.
133. Guo,J.U., Su,Y., Shin,J.H., Shin,J., Li,H., Xie,B., Zhong,C., Hu,S.,
Le,T., Fan,G. et al. (2014) Distribution, recognition and regulation
of non-CpG methylation in the adult mammalian brain. Nat.
Neurosci., 17, 215–222.
134. Schultz,M.D., He,Y., Whitaker,J.W., Hariharan,M.,
Mukamel,E.A., Leung,D., Rajagopal,N., Nery,J.R., Urich,M.A.,
Chen,H. et al. (2015) Human body epigenome maps reveal
noncanonical DNA methylation variation. Nature, 523, 212–216.
135. Ziller,M.J., Muller,F., Liao,J., Zhang,Y., Gu,H., Bock,C., Boyle,P.,
Epstein,C.B., Bernstein,B.E., Lengauer,T. et al. (2011) Genomic
distribution and inter-sample variation of non-CpG methylation
across human cell types. PLoS Genet., 7, e1002389.
136. Arand,J., Spieler,D., Karius,T., Branco,M.R., Meilinger,D.,
Meissner,A., Jenuwein,T., Xu,G., Leonhardt,H., Wolf,V. et al.
(2012) In vivo control of CpG and non-CpG DNA methylation by
DNA methyltransferases. PLoS Genet., 8, e1002750.
137. Gabel,H.W., Kinde,B., Stroud,H., Gilbert,C.S., Harmin,D.A.,
Kastan,N.R., Hemberg,M., Ebert,D.H. and Greenberg,M.E. (2015)
Disruption of DNA-methylation-dependent long gene repression in
Rett syndrome. Nature, 522, 89–93.
138. Chen,L., Chen,K., Lavery,L.A., Baker,S.A., Shaw,C.A., Li,W. and
Zoghbi,H.Y. (2015) MeCP2 binds to non-CG methylated DNA as
neurons mature, influencing transcription and the timing of onset
for Rett syndrome. Proc. Natl. Acad. Sci. U.S.A., 112, 5509–5514.
139. Jurkowska,R.Z., Siddique,A.N., Jurkowski,T.P. and Jeltsch,A.
(2011) Approaches to enzyme and substrate design of the murine
Dnmt3a DNA methyltransferase. Chembiochem, 12, 1589–1594.
140. Lin,I.G., Han,L., Taghva,A., O’Brien,L.E. and Hsieh,C.L. (2002)
Murine de novo methyltransferase Dnmt3a demonstrates strand
asymmetry and site preference in the methylation of DNA in vitro.
Mol. Cell. Biol., 22, 704–723.
141. Handa,V. and Jeltsch,A. (2005) Profound flanking sequence
preference of Dnmt3a and Dnmt3b mammalian DNA
methyltransferases shape the human epigenome. J. Mol. Biol., 348,
1103–1112.
142. Holz-Schietinger,C. and Reich,N.O. (2010) The inherent
processivity of the human de novo methyltransferase 3A
(DNMT3A) is enhanced by DNMT3L. J. Biol. Chem., 285,
29091–29100.
143. Rajavelu,A., Jurkowska,R.Z., Fritz,J. and Jeltsch,A. (2012)
Function and disruption of DNA methyltransferase 3a cooperative
DNA binding and nucleoprotein filament formation. Nucleic Acids
Res., 40, 569–580.
144. Emperle,M., Rajavelu,A., Reinhardt,R., Jurkowska,R.Z. and
Jeltsch,A. (2014) Cooperative DNA binding and protein/DNA
fiber formation increases the activity of the Dnmt3a DNA
methyltransferase. J. Biol. Chem., 289, 29602–29613.
145. Jeltsch,A. and Jurkowska,R.Z. (2013) Multimerization of the
dnmt3a DNA methyltransferase and its functional implications.
Prog. Mol. Biol. Transl. Sci., 117, 445–464.
146. Gowher,H., Stockdale,C.J., Goyal,R., Ferreira,H.,
Owen-Hughes,T. and Jeltsch,A. (2005) De novo methylation of
nucleosomal DNA by the mammalian Dnmt1 and Dnmt3A DNA
methyltransferases. Biochemistry, 44, 9899–9904.
147. Takeshima,H., Suetake,I. and Tajima,S. (2008) Mouse Dnmt3a
preferentially methylates linker DNA and is inhibited by histone
H1. J. Mol. Biol., 383, 810–821.
148. Felle,M., Hoffmeister,H., Rothammer,J., Fuchs,A., Exler,J.H. and
Langst,G. (2011) Nucleosomes protect DNA from DNA
methylation in vivo and in vitro. Nucleic Acids Res., 39, 6956–6969.
149. Morselli,M., Pastor,W.A., Montanini,B., Nee,K., Ferrari,R.,
Fu,K., Bonora,G., Rubbi,L., Clark,A.T., Ottonello,S. et al. (2015)
In vivo targeting of de novo DNA methylation by histone
modifications in yeast and mouse. Elife, 4, e06205.
150. Datta,J., Majumder,S., Bai,S., Ghoshal,K., Kutay,H., Smith,D.S.,
Crabb,J.W. and Jacob,S.T. (2005) Physical and functional
interaction of DNA methyltransferase 3A with Mbd3 and Brg1 in
mouse lymphosarcoma cells. Cancer Res., 65, 10891–10900.
151. Cai,Y., Geutjes,E.J., de Lint,K., Roepman,P., Bruurs,L., Yu,L.R.,
Wang,W., van Blijswijk,J., Mohammad,H., de Rink,I. et al. (2014)
The NuRD complex cooperates with DNMTs to maintain silencing
of key colorectal tumor suppressor genes. Oncogene, 33, 2157–2168.
152. Geiman,T.M., Sankpal,U.T., Robertson,A.K., Zhao,Y. and
Robertson,K.D. (2004) DNMT3B interacts with hSNF2H
chromatin remodeling enzyme, HDACs 1 and 2, and components of
the histone methylation system. Biochem. Biophys. Res. Commun.,
318, 544–555.
153. Zhu,H., Geiman,T.M., Xi,S., Jiang,Q., Schmidtmann,A., Chen,T.,
Li,E. and Muegge,K. (2006) Lsh is involved in de novo methylation
of DNA. EMBO J., 25, 335–345.
154. Myant,K. and Stancheva,I. (2008) LSH cooperates with DNA
methyltransferases to repress transcription.Mol. Cell. Biol., 28,
215–226.
155. Muegge,K. (2005) Lsh, a guardian of heterochromatin at repeat
elements. Biochem. Cell Biol., 83, 548–554.
156. Termanis,A., Torrea,N., Culley,J., Kerr,A., Ramsahoye,B. and
Stancheva,I. (2016) The SNF2 family ATPase LSH promotes
cell-autonomous de novo DNA methylation in somatic cells.
Nucleic Acids Res., doi:10.1093/nar/gkw424.
157. Jurkowska,R.Z., Rajavelu,A., Anspach,N., Urbanke,C.,
Jankevicius,G., Ragozin,S., Nellen,W. and Jeltsch,A. (2011)
Oligomerization and binding of the Dnmt3a DNA
methyltransferase to parallel DNA molecules: heterochromatic
localization and role of Dnmt3L. J. Biol. Chem., 286, 24200–24207.
158. Kareta,M.S., Botello,Z.M., Ennis,J.J., Chou,C. and Chedin,F.
(2006) Reconstitution and mechanism of the stimulation of de novo
methylation by human DNMT3L. J. Biol. Chem., 281,
25893–25902.
159. Li,J.Y., Pu,M.T., Hirasawa,R., Li,B.Z., Huang,Y.N., Zeng,R.,
Jing,N.H., Chen,T., Li,E., Sasaki,H. et al. (2007) Synergistic
function of DNA methyltransferases Dnmt3a and Dnmt3b in the
methylation of Oct4 and Nanog.Mol. Cell. Biol., 27, 8748–8759.
160. Noh,K.M., Wang,H., Kim,H.R., Wenderski,W., Fang,F., Li,C.H.,
Dewell,S., Hughes,S.H., Melnick,A.M., Patel,D.J. et al. (2015)
Engineering of a histone-recognition domain in Dnmt3a alters the
epigenetic landscape and phenotypic features of mouse ESCs.Mol.
Cell, 59, 89–103.
161. Hodges,E., Smith,A.D., Kendall,J., Xuan,Z., Ravi,K., Rooks,M.,
Zhang,M.Q., Ye,K., Bhattacharjee,A., Brizuela,L. et al. (2009)
High definition profiling of mammalian DNA methylation by array
capture and single molecule bisulfite sequencing. Genome Res., 19,
1593–1605.
D
ow
nloaded from
 https://academ
ic.oup.com
/nar/article-abstract/44/18/8556/2468361 by Acquisitions user on 13 D
ecem
ber 2018
Nucleic Acids Research, 2016, Vol. 44, No. 18 8575
162. Weber,M., Hellmann,I., Stadler,M.B., Ramos,L., Paabo,S.,
Rebhan,M. and Schubeler,D. (2007) Distribution, silencing
potential and evolutionary impact of promoter DNA methylation
in the human genome. Nat. Genet., 39, 457–466.
163. Barski,A., Cuddapah,S., Cui,K., Roh,T.Y., Schones,D.E., Wang,Z.,
Wei,G., Chepelev,I. and Zhao,K. (2007) High-resolution profiling
of histone methylations in the human genome. Cell, 129, 823–837.
164. Edmunds,J.W., Mahadevan,L.C. and Clayton,A.L. (2008) Dynamic
histone H3 methylation during gene induction: HYPB/Setd2
mediates all H3K36 trimethylation. EMBO J., 27, 406–420.
165. Guenther,M.G., Levine,S.S., Boyer,L.A., Jaenisch,R. and
Young,R.A. (2007) A chromatin landmark and transcription
initiation at most promoters in human cells. Cell, 130, 77–88.
166. Larschan,E., Alekseyenko,A.A., Gortchakov,A.A., Peng,S., Li,B.,
Yang,P., Workman,J.L., Park,P.J. and Kuroda,M.I. (2007) MSL
complex is attracted to genes marked by H3K36 trimethylation
using a sequence-independent mechanism.Mol. Cell, 28, 121–133.
167. Vakoc,C.R., Sachdeva,M.M., Wang,H. and Blobel,G.A. (2006)
Profile of histone lysine methylation across transcribed mammalian
chromatin.Mol. Cell. Biol., 26, 9185–9195.
168. Ball,M.P., Li,J.B., Gao,Y., Lee,J.H., LeProust,E.M., Park,I.H.,
Xie,B., Daley,G.Q. and Church,G.M. (2009) Targeted and
genome-scale strategies reveal gene-body methylation signatures in
human cells. Nat. Biotechnol., 27, 361–368.
169. Hellman,A. and Chess,A. (2007) Gene body-specific methylation on
the active X chromosome. Science, 315, 1141–1143.
170. Kolasinska-Zwierz,P., Down,T., Latorre,I., Liu,T., Liu,X.S. and
Ahringer,J. (2009) Differential chromatin marking of introns and
expressed exons by H3K36me3. Nat. Genet., 41, 376–381.
171. Ernst,J., Kheradpour,P., Mikkelsen,T.S., Shoresh,N., Ward,L.D.,
Epstein,C.B., Zhang,X., Wang,L., Issner,R., Coyne,M. et al. (2011)
Mapping and analysis of chromatin state dynamics in nine human
cell types. Nature, 473, 43–49.
172. Purdy,M.M., Holz-Schietinger,C. and Reich,N.O. (2010)
Identification of a second DNA binding site in human DNA
methyltransferase 3A by substrate inhibition and domain deletion.
Arch. Biochem. Biophys., 498, 13–22.
173. van Nuland,R., van Schaik,F.M., Simonis,M., van Heesch,S.,
Cuppen,E., Boelens,R., Timmers,H.M. and van Ingen,H. (2013)
Nucleosomal DNA binding drives the recognition of
H3K36-methylated nucleosomes by the PSIP1-PWWP domain.
Epigenetics Chromatin, 6, 12.
174. Fuks,F., Hurd,P.J., Deplus,R. and Kouzarides,T. (2003) The DNA
methyltransferases associate with HP1 and the SUV39H1 histone
methyltransferase. Nucleic Acids Res., 31, 2305–2312.
175. Li,H., Rauch,T., Chen,Z.X., Szabo,P.E., Riggs,A.D. and
Pfeifer,G.P. (2006) The histone methyltransferase SETDB1 and the
DNA methyltransferase DNMT3A interact directly and localize to
promoters silenced in cancer cells. J. Biol. Chem., 281, 19489–19500.
176. Vire,E., Brenner,C., Deplus,R., Blanchon,L., Fraga,M., Didelot,C.,
Morey,L., Van Eynde,A., Bernard,D., Vanderwinden,J.M. et al.
(2006) The Polycomb group protein EZH2 directly controls DNA
methylation. Nature, 439, 871–874.
177. Kimura,H. and Shiota,K. (2003) Methyl-CpG-binding protein,
MeCP2, is a target molecule for maintenance DNA
methyltransferase, Dnmt1. J. Biol. Chem., 278, 4806–4812.
178. Fuks,F., Hurd,P.J., Wolf,D., Nan,X., Bird,A.P. and Kouzarides,T.
(2003) The methyl-CpG-binding protein MeCP2 links DNA
methylation to histone methylation. J. Biol. Chem., 278, 4035–4040.
179. Suzuki,M., Yamada,T., Kihara-Negishi,F., Sakurai,T., Hara,E.,
Tenen,D.G., Hozumi,N. and Oikawa,T. (2006) Site-specific DNA
methylation by a complex of PU.1 and Dnmt3a/b. Oncogene, 25,
2477–2488.
180. Brenner,C., Deplus,R., Didelot,C., Loriot,A., Vire,E., De Smet,C.,
Gutierrez,A., Danovi,D., Bernard,D., Boon,T. et al. (2005) Myc
represses transcription through recruitment of DNA
methyltransferase corepressor. EMBO J., 24, 336–346.
181. Fuks,F., Burgers,W.A., Godin,N., Kasai,M. and Kouzarides,T.
(2001) Dnmt3a binds deacetylases and is recruited by a
sequence-specific repressor to silence transcription. EMBO J., 20,
2536–2544.
182. Kim,S.H., Park,J., Choi,M.C., Kim,H.P., Park,J.H., Jung,Y.,
Lee,J.H., Oh,D.Y., Im,S.A., Bang,Y.J. et al. (2007) Zinc-fingers and
homeoboxes 1 (ZHX1) binds DNA methyltransferase (DNMT) 3B
to enhance DNMT3B-mediated transcriptional repression.
Biochem. Biophys. Res. Commun., 355, 318–323.
183. Lehnertz,B., Ueda,Y., Derijck,A.A., Braunschweig,U.,
Perez-Burgos,L., Kubicek,S., Chen,T., Li,E., Jenuwein,T. and
Peters,A.H. (2003) Suv39h-mediated histone H3 lysine 9
methylation directs DNA methylation to major satellite repeats at
pericentric heterochromatin. Curr. Biol., 13, 1192–1200.
184. Hata,K., Okano,M., Lei,H. and Li,E. (2002) Dnmt3L cooperates
with the Dnmt3 family of de novo DNA methyltransferases to
establish maternal imprints in mice. Development, 129, 1983–1993.
185. Chedin,F., Lieber,M.R. and Hsieh,C.L. (2002) The DNA
methyltransferase-like protein DNMT3L stimulates de novo
methylation by Dnmt3a. Proc. Natl. Acad. Sci. U.S.A., 99,
16916–16921.
186. Chen,Z.X., Mann,J.R., Hsieh,C.L., Riggs,A.D. and Chedin,F.
(2005) Physical and functional interactions between the human
DNMT3L protein and members of the de novo methyltransferase
family. J. Cell. Biochem., 95, 902–917.
187. Suetake,I., Shinozaki,F., Miyagawa,J., Takeshima,H. and Tajima,S.
(2004) DNMT3L stimulates the DNA methylation activity of
Dnmt3a and Dnmt3b through a direct interaction. J. Biol. Chem.,
279, 27816–27823.
188. Gowher,H., Liebert,K., Hermann,A., Xu,G. and Jeltsch,A. (2005)
Mechanism of stimulation of catalytic activity of Dnmt3A and
Dnmt3B DNA-(cytosine-C5)-methyltransferases by Dnmt3L. J.
Biol. Chem., 280, 13341–13348.
189. Bourc’his,D., Xu,G.L., Lin,C.S., Bollman,B. and Bestor,T.H.
(2001) Dnmt3L and the establishment of maternal genomic
imprints. Science, 294, 2536–2539.
190. Bourc’his,D. and Bestor,T.H. (2004) Meiotic catastrophe and
retrotransposon reactivation in male germ cells lacking Dnmt3L.
Nature, 431, 96–99.
191. Neri,F., Krepelova,A., Incarnato,D., Maldotti,M., Parlato,C.,
Galvagni,F., Matarese,F., Stunnenberg,H.G. and Oliviero,S. (2013)
Dnmt3L antagonizes DNA methylation at bivalent promoters and
favors DNAmethylation at gene bodies in ESCs. Cell, 155, 121–134.
192. Duymich,C.E., Charlet,J., Yang,X.J., Jones,P.A. and Liang,G.N.
(2016) DNMT3B isoforms without catalytic activity stimulate gene
body methylation as accessory proteins in somatic cells. Nat.
Commun., 7, 11453.
193. Holz-Schietinger,C. and Reich,N.O. (2012) RNA modulation of the
human DNA methyltransferase 3A. Nucleic Acids Res., 40,
8550–8557.
194. Schmitz,K.M., Mayer,C., Postepska,A. and Grummt,I. (2010)
Interaction of noncoding RNA with the rDNA promoter mediates
recruitment of DNMT3b and silencing of rRNA genes. Genes Dev.,
24, 2264–2269.
195. Bierhoff,H., Schmitz,K., Maass,F., Ye,J. and Grummt,I. (2010)
Noncoding transcripts in sense and antisense orientation regulate
the epigenetic state of ribosomal RNA genes. Cold Spring Harb.
Symp. Quant. Biol., 75, 357–364.
196. Deplus,R., Blanchon,L., Rajavelu,A., Boukaba,A., Defrance,M.,
Luciani,J., Rothe,F., Dedeurwaerder,S., Denis,H., Brinkman,A.B.
et al. (2014) Regulation of DNA methylation patterns by
CK2-mediated phosphorylation of Dnmt3a. Cell Rep., 8, 743–753.
197. Li,Y., Han,J., Zhang,Y., Cao,F., Liu,Z., Li,S., Wu,J., Hu,C.,
Wang,Y., Shuai,J. et al. (2016) Structural basis for activity
regulation of MLL family methyltransferases.Nature, 530, 447–452.
198. Muller,M.M., Fierz,B., Bittova,L., Liszczak,G. and Muir,T.W.
(2016) A two-state activation mechanism controls the histone
methyltransferase Suv39h1. Nat. Chem. Biol., 12, 188–193.
199. Jiao,L. and Liu,X. (2015) Structural basis of histone H3K27
trimethylation by an active polycomb repressive complex 2. Science,
350, aac4383.
200. Holoch,D. and Moazed,D. (2015) RNA-mediated epigenetic
regulation of gene expression. Nat. Rev. Genet., 16, 71–84.
201. Rinn,J.L. and Chang,H.Y. (2012) Genome regulation by long
noncoding RNAs. Annu Rev Biochem, 81, 145–166.
202. Matzke,M.A. and Mosher,R.A. (2014) RNA-directed DNA
methylation: An epigenetic pathway of increasing complexity. Nat.
Rev. Genet., 15, 394–408.
203. Iwasaki,Y.W., Siomi,M.C. and Siomi,H. (2015) PIWI-Interacting
RNA: Its biogenesis and functions. Annu. Rev. Biochem., 84,
405–433.
D
ow
nloaded from
 https://academ
ic.oup.com
/nar/article-abstract/44/18/8556/2468361 by Acquisitions user on 13 D
ecem
ber 2018
